☰

Ian Campbell - Publications

Affiliations: 
1931-1959 Geology California Institute of Technology, Pasadena, CA 
 1959-1969 California Division of Mines and Geology 
Area:
petrology
Website:
http://www.encyclopedia.com/science/dictionaries-thesauruses-pictures-and-press-releases/campbell-ian
Tree Info Similar researchers PubMed Report error

0/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches (unlikely to be authored by this person)
2018 Lee JEA, Li N, Rowley SM, Cheasley D, Zethoven M, McInerny S, Gorringe KL, James PA, Campbell IG. Molecular analysis of PALB2 associated breast cancers. The Journal of Pathology. PMID 29431189 DOI: 10.1002/path.5055  0.295
2021 Li N, Zethoven M, McInerny S, Devereux L, Huang YK, Thio N, Cheasley D, Gutiérrez-Enríquez S, Moles-Fernández A, Diez O, Nguyen-Dumont T, Southey MC, Hopper JL, Simard J, Dumont M, ... ... Campbell IG, et al. Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects. Npj Breast Cancer. 7: 52. PMID 33980861 DOI: 10.1038/s41523-021-00255-3  0.294
2016 Li N, Thompson ER, Rowley SM, McInerny S, Devereux L, Goode D, Investigators L, Wong-Brown MW, Scott RJ, Trainer AH, Gorringe KL, James PA, Campbell IG. Reevaluation of RINT1 as a breast cancer predisposition gene. Breast Cancer Research and Treatment. PMID 27544226 DOI: 10.1007/s10549-016-3944-3  0.29
2015 Thompson ER, Gorringe KL, Rowley SM, Li N, McInerny S, Wong-Brown MW, Devereux L, Li J, Trainer AH, Mitchell G, Scott RJ, James PA, Campbell IG. Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context. Scientific Reports. 5: 14800. PMID 26455428 DOI: 10.1038/srep14800  0.283
2012 Thompson ER, Gorringe KL, Choong DY, Eccles DM, Mitchell G, Campbell IG. Analysis of KLLN as a high-penetrance breast cancer predisposition gene. Breast Cancer Research and Treatment. 134: 543-7. PMID 22580995 DOI: 10.1007/s10549-012-2088-3  0.283
2016 Campbell I, Thompson E, Rowely S, Li N, McInerny S, Devereux L, Wong-Brown M, Trainer A, Mitchell G, Scott R, James P. Abstract P2-09-02: Panel testing for familial breast cancer: Tension at the boundary of research and clinical care Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P2-09-02  0.28
2020 Cheasley D, Devereux L, Hughes S, Nickson C, Procopio P, Lee G, Li N, Pridmore V, Elder K, Bruce Mann G, Kader T, Rowley SM, Fox SB, Byrne D, Saunders H, ... ... Campbell IG, et al. The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic density. Npj Breast Cancer. 6: 34. PMID 32802943 DOI: 10.1038/s41523-020-00176-7  0.279
2020 Cheasley D, Devereux L, Hughes S, Nickson C, Procopio P, Lee G, Li N, Pridmore V, Elder K, Bruce Mann G, Kader T, Rowley SM, Fox SB, Byrne D, Saunders H, ... ... Campbell IG, et al. The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic density. Npj Breast Cancer. 6: 34. PMID 33574272 DOI: 10.1038/s41523-020-00176-7  0.279
2015 Li J, Meeks H, Feng BJ, Healey S, Thorne H, Makunin I, Ellis J, Campbell I, Southey M, Mitchell G, Clouston D, Kirk J, Goldgar D, Chenevix-Trench G. Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families. Journal of Medical Genetics. PMID 26534844 DOI: 10.1136/Jmedgenet-2015-103452  0.278
2013 Thompson ER, Rowley SM, Sawyer S, kConfab, Eccles DM, Trainer AH, Mitchell G, James PA, Campbell IG. Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer. Plos One. 8: e54772. PMID 23372765 DOI: 10.1371/journal.pone.0054772  0.276
2018 Gorringe K, Hughes S, Nickson C, Devereux L, Pridmore V, Rowley S, Byrne D, Cheasley D, Kavanagh A, Mann G, Fox S, Campbell I. Abstract P3-04-06: Genomic analysis of cancers arising in breasts with different mammographic density Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P3-04-06  0.274
2003 Clancy JL, Henderson MJ, Russell AJ, Anderson DW, Bova RJ, Campbell IG, Choong DY, Macdonald GA, Mann GJ, Nolan T, Brady G, Olopade OI, Woollatt E, Davies MJ, Segara D, et al. EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer. Oncogene. 22: 5070-81. PMID 12902990 DOI: 10.1038/Sj.Onc.1206775  0.273
2013 Southey MC, Park DJ, Nguyen-Dumont T, Campbell I, Thompson E, Trainer AH, Chenevix-Trench G, Simard J, Dumont M, Soucy P, Thomassen M, Jønson L, Pedersen IS, Hansen TV, et al. COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration. Breast Cancer Research : Bcr. 15: 402. PMID 23809231 DOI: 10.1186/Bcr3434  0.273
2006 Williams LH, Choong D, Johnson SA, Campbell IG. Genetic and epigenetic analysis of CHEK2 in sporadic breast, colon, and ovarian cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 6967-72. PMID 17145815 DOI: 10.1158/1078-0432.CCR-06-1770  0.273
2002 Campbell IG, Baxter SW, Eccles DM, Choong DYH. Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer Breast Cancer Research : Bcr. 4: R14. PMID 12473175 DOI: 10.1186/bcr457  0.271
2016 Campbell I, Trainer A, Devereux L, Young M, Mitchell G, Rowley S, Li N, James P, Thompson E. Abstract P2-09-03: Breast cancer prevention: Is it time for population-based mutation screening of high risk genes? Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P2-09-03  0.27
2008 Gorringe KL, Choong DY, Visvader JE, Lindeman GJ, Campbell IG. BARD1 variants are not associated with breast cancer risk in Australian familial breast cancer. Breast Cancer Research and Treatment. 111: 505-9. PMID 17972171 DOI: 10.1007/s10549-007-9799-x  0.269
2017 Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S, Lindström S, Hui S, Lemaçon A, Soucy P, Dennis J, Jiang X, Rostamianfar A, Finucane H, Bolla MK, McGuffog L, ... Campbell I, et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nature Genetics. PMID 29058716 DOI: 10.1038/Ng.3785  0.269
2012 Thompson E, Doyle M, Ellul J, Li J, Campbell I. Identification of breast cancer susceptibility genes using whole exome sequencing Hereditary Cancer in Clinical Practice. 10: 1-1. DOI: 10.1186/1897-4287-10-S2-A41  0.267
2012 Hilbers FS, Wijnen JT, Hoogerbrugge N, Oosterwijk JC, Collee MJ, Peterlongo P, Radice P, Manoukian S, Feroce I, Capra F, Couch FJ, Wang X, Guidugli L, Offit K, Shah S, ... Campbell IG, et al. Rare variants in XRCC2 as breast cancer susceptibility alleles. Journal of Medical Genetics. 49: 618-20. PMID 23054243 DOI: 10.1136/jmedgenet-2012-101191  0.267
2023 Stolarova L, Kleiblova P, Zemankova P, Stastna B, Janatova M, Soukupova J, Achatz MI, Ambrosone C, Apostolou P, Arun BK, Auer P, Barnard M, Bertelsen B, Blok MJ, Boddicker N, ... ... Campbell I, et al. ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. OF1-OF14. PMID 37449874 DOI: 10.1158/1078-0432.CCR-23-0212  0.266
2008 Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M, Trivett M, Thompson ER, Ramakrishna M, Gorringe KL, Polyak K, Haviv I, Campbell IG. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nature Genetics. 40: 650-5. PMID 18408720 DOI: 10.1038/ng.117  0.266
2022 Hakkaart C, Pearson JF, Marquart L, Dennis J, Wiggins GAR, Barnes DR, Robinson BA, Mace PD, Aittomäki K, Andrulis IL, Arun BK, Azzollini J, Balmaña J, Barkardottir RB, Belhadj S, ... ... Campbell I, et al. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers. Communications Biology. 5: 1061. PMID 36203093 DOI: 10.1038/s42003-022-03978-6  0.266
2015 Thompson ER, Gorringe KL, Rowley SM, Wong-Brown MW, McInerny S, Li N, Trainer AH, Devereux L, Doyle MA, Li J, Lupat R, Delatycki MB, Mitchell G, James PA, ... ... Campbell IG, et al. Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls. Breast Cancer Research : Bcr. 17: 111. PMID 26283626 DOI: 10.1186/s13058-015-0627-7  0.265
2019 Figlioli G, Bogliolo M, Catucci I, Caleca L, Lasheras SV, Pujol R, Kiiski JI, Muranen TA, Barnes DR, Dennis J, Michailidou K, Bolla MK, Leslie G, Aalfs CM, ... ... Campbell IG, et al. The :p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. Npj Breast Cancer. 5: 38. PMID 31700994 DOI: 10.1038/s41523-019-0127-5  0.264
2012 Thompson ER, Boyle SE, Johnson J, Ryland GL, Sawyer S, Choong DY, kConFab, Chenevix-Trench G, Trainer AH, Lindeman GJ, Mitchell G, James PA, Campbell IG. Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients. Human Mutation. 33: 95-9. PMID 21990120 DOI: 10.1002/humu.21625  0.264
2020 Feng H, Gusev A, Pasaniuc B, Wu L, Long J, Abu-Full Z, Aittomäki K, Andrulis IL, Anton-Culver H, Antoniou AC, Arason A, Arndt V, Aronson KJ, Arun BK, Asseryanis E, ... Campbell I, et al. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status. Genetic Epidemiology. PMID 32115800 DOI: 10.1002/gepi.22288  0.264
2019 Ferreira MA, Gamazon ER, Al-Ejeh F, Aittomäki K, Andrulis IL, Anton-Culver H, Arason A, Arndt V, Aronson KJ, Arun BK, Asseryanis E, Azzollini J, Balmaña J, Barnes DR, Barrowdale D, ... Campbell I, et al. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. Nature Communications. 10: 1741. PMID 30988301 DOI: 10.1038/s41467-018-08053-5  0.264
2015 Peterlongo P, Catucci I, Colombo M, Caleca L, Mucaki E, Bogliolo M, Marin M, Damiola F, Bernard L, Pensotti V, Volorio S, Dall'Olio V, Meindl A, Bartram C, Sutter C, ... Campbell I, et al. FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity, and is a familial breast cancer risk factor. Human Molecular Genetics. PMID 26130695 DOI: 10.1093/Hmg/Ddv251  0.264
2018 Campbell I, Rowley S, Devereux L, McInerny S, Grewal N, Young M, Lee A, Trainer A, James P. Abstract PD1-07: Population genetic testing for breast cancer susceptibility Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd1-07  0.263
2019 Cheasley D, Li N, Rowley SM, Elder K, Mann GB, Loi S, Savas P, Goode DL, Kader T, Zethoven M, Semple T, Fox SB, Pang JM, Byrne D, Devereux L, ... ... Campbell IG, et al. Molecular comparison of interval and screen-detected breast cancers. The Journal of Pathology. PMID 30746706 DOI: 10.1002/path.5251  0.263
1998 Eccles DM, Englefield P, Soulby MA, Campbell IG. BRCA1 mutations in southern England British Journal of Cancer. 77: 2199-2203. PMID 9649133 DOI: 10.1038/Bjc.1998.366  0.262
2012 Campbell IG, Bryan EJ. Mapping of tumor suppressor genes in ovarian cancers. Methods in Molecular Medicine. 39: 365-74. PMID 21340792 DOI: 10.1385/1-59259-071-3:365  0.261
2022 Lim BWX, Li N, Mahale S, Mcinerny S, Zethoven M, Rowley SM, Huynh J, Wang T, Lee JEA, Friedman M, Devereux L, Scott RJ, Sloan EK, James PA, Campbell IG. Somatic Inactivation of Breast Cancer Predisposition Genes in Tumours Associated with Pathogenic Germline Variants. Journal of the National Cancer Institute. PMID 36315097 DOI: 10.1093/jnci/djac196  0.261
2016 Thompson ER, Rowley SM, Li N, McInerny S, Devereux L, Wong-Brown MW, Trainer AH, Mitchell G, Scott RJ, James PA, Campbell IG. Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26786923 DOI: 10.1200/JCO.2015.63.7454  0.261
2018 Kader T, Hill P, Opeskin K, Goode D, Elder K, Pang J, Fox S, Mann G, Campbell I, Gorringe K. Abstract PD1-12: Identification of copy number alterations associated with the progression of high risk premalignant breast lesions to breast carcinoma Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd1-12  0.26
2016 Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q, Barrowdale D, Frost D, McGuffog L, Ellis S, Feng B, Buys SS, Hopper JL, Southey MC, ... ... Campbell IG, et al. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. Journal of the National Cancer Institute. 108. PMID 26586665 DOI: 10.1093/Jnci/Djv315  0.259
2006 Campbell IG, Phillips WA, Choong DYH. Genetic and epigenetic analysis of the putative tumor suppressor km23 in primary ovarian, breast, and colorectal cancers Clinical Cancer Research. 12: 3713-3715. PMID 16778097 DOI: 10.1158/1078-0432.CCR-06-0800  0.259
2018 Rowley SM, Mascarenhas L, Devereux L, Li N, Amarasinghe KC, Zethoven M, Lee JEA, Lewis A, Morgan JA, Limb S, Young MA, James PA, Trainer AH, Campbell IG. Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 30254378 DOI: 10.1038/s41436-018-0277-0  0.259
2016 Kar SP, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ, Kibel AS, Dansonka-Mieszkowska A, Michael A, Dieffenbach AK, ... Campbell I, et al. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discovery. PMID 27432226 DOI: 10.1158/2159-8290.Cd-15-1227  0.258
2012 Thompson ER, Doyle MA, Ryland GL, Rowley SM, Choong DY, Tothill RW, Thorne H, Barnes DR, Li J, Ellul J, Philip GK, Antill YC, James PA, Trainer AH, ... ... Campbell IG, et al. Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles. Plos Genetics. 8: e1002894. PMID 23028338 DOI: 10.1371/journal.pgen.1002894  0.258
2018 Li N, Rowley SM, Thompson ER, McInerny S, Devereux L, Amarasinghe KC, Zethoven M, Lupat R, Goode D, Li J, Trainer AH, Gorringe KL, James PA, Campbell IG. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs. Breast Cancer Research : Bcr. 20: 3. PMID 29316957 DOI: 10.1186/s13058-017-0929-z  0.257
2004 Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, Hooi CS, Cristiano BE, Pearson RB, Phillips WA. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Research. 64: 7678-81. PMID 15520168 DOI: 10.1158/0008-5472.CAN-04-2933  0.257
2003 Sutherland KD, Visvader JE, Choong DY, Sum EY, Lindeman GJ, Campbell IG. Mutational analysis of the LMO4 gene, encoding a BRCA1-interacting protein, in breast carcinomas. International Journal of Cancer. Journal International Du Cancer. 107: 155-8. PMID 12925972 DOI: 10.1002/ijc.11343  0.257
2005 Thompson E, Dragovic RL, Stephenson SA, Eccles DM, Campbell IG, Dobrovic A. A novel duplication polymorphism in the FANCA promoter and its association with breast and ovarian cancer. Bmc Cancer. 5: 43. PMID 15860134 DOI: 10.1186/1471-2407-5-43  0.257
2019 Li N, McInerny S, Zethoven M, Cheasley D, Lim BWX, Rowley SM, Devereux L, Grewal N, Ahmadloo S, Byrne D, Lee JEA, Li J, Fox SB, John T, Antill Y, ... ... Campbell IG, et al. Combined tumor sequencing and case/control analyses of RAD51C in breast cancer. Journal of the National Cancer Institute. PMID 30949688 DOI: 10.1093/Jnci/Djz045  0.255
2004 Campbell IG, Choong D, Chenevix-Trench G. No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer. Breast Cancer Research : Bcr. 6: R366-71. PMID 15217503 DOI: 10.1186/bcr803  0.255
2005 Campbell IG. Review of: The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk Breast Cancer Online. 8: 1-3. DOI: 10.1017/S1470903105004748  0.255
2006 Campbell IG, Eccles DM, Choong DYH. No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer Cancer Letters. 240: 195-197. PMID 16239061 DOI: 10.1016/j.canlet.2005.09.003  0.254
2008 Gorringe KL, Choong DY, Lindeman GJ, Visvader JE, Campbell IG. Breast cancer risk and the BRCA1 interacting protein CTIP. Breast Cancer Research and Treatment. 112: 351-2. PMID 18095152 DOI: 10.1007/s10549-007-9862-7  0.254
2013 Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB, Soucy P, Fredericksen Z, Barrowdale D, Dennis J, Gaudet MM, Dicks E, Kosel M, Healey S, Sinilnikova OM, ... ... Campbell I, et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. Plos Genetics. 9: e1003212. PMID 23544013 DOI: 10.1371/Journal.Pgen.1003212  0.254
2015 Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, ... Campbell I, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. PMID 25940428 DOI: 10.1016/J.Ygyno.2015.04.034  0.252
2015 Eccles DM, Li N, Handwerker R, Maishman T, Copson ER, Durcan LT, Gerty SM, Jones L, Evans DG, Haywood L, Campbell I. Genetic testing in a cohort of young patients with HER2 amplified breast cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 26681682 DOI: 10.1093/Annonc/Mdv592  0.251
2017 Samimi G, Bernardini MQ, Brody LC, Caga-Anan CF, Campbell IG, Chenevix-Trench G, Couch FJ, Dean M, de Hullu JA, Domchek SM, Drapkin R, Spencer Feigelson H, Friedlander M, Gaudet MM, Harmsen MG, et al. Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016703439. PMID 28398847 DOI: 10.1200/Jco.2016.70.3439  0.25
2020 Silvestri V, Leslie G, Barnes DR, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Barkardottir RB, Barroso A, Barrowdale D, Benitez J, Bonanni B, Borg A, Buys SS, ... Campbell I, et al. Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Jama Oncology. PMID 32614418 DOI: 10.1001/Jamaoncol.2020.2134  0.25
2012 Roder D, De Silva P, Zorbas H, Kollias J, Malycha P, Pyke C, Campbell I, Webster F. Survival from synchronous bilateral breast cancer: The experience of surgeons participating in the breast audit of the society of breast surgeons of Australia and New Zealand Asian Pacific Journal of Cancer Prevention. 13: 1413-1418. PMID 22799341 DOI: 10.7314/APJCP.2012.13.4.1413  0.25
2016 Seneviratne S, Lawrenson R, Harvey V, Ramsaroop R, Elwood M, Scott N, Sarfati D, Campbell I. Stage of breast cancer at diagnosis in New Zealand: impacts of socio-demographic factors, breast cancer screening and biology. Bmc Cancer. 16: 129. PMID 26896237 DOI: 10.1186/s12885-016-2177-5  0.25
2004 Sutherland KD, Lindeman GJ, Choong DY, Wittlin S, Brentzell L, Phillips W, Campbell IG, Visvader JE. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas. Oncogene. 23: 7726-33. PMID 15361843 DOI: 10.1038/sj.onc.1207787  0.248
1998 Mavridou D, Gornall R, Campbell IG, Eccles DM. TP53 intron 6 polymorphism and the risk of ovarian and breast cancer [1] British Journal of Cancer. 77: 676-677. PMID 9484829 DOI: 10.1038/bjc.1998.108  0.247
2016 Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, Pooley KA, Shah M, Bolla MK, Wang Q, Dennis J, Ahmad J, Thompson ER, Damiola F, ... ... Campbell IG, et al. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. Journal of Medical Genetics. PMID 26921362 DOI: 10.1136/Jmedgenet-2015-103529  0.247
2021 Lao C, Elwood M, Kuper-Hommel M, Campbell I, Lawrenson R. Impact of menopausal status on risk of metastatic recurrence of breast cancer. Menopause (New York, N.Y.). PMID 34260475 DOI: 10.1097/GME.0000000000001817  0.247
2006 Arnold JM, Choong DY, Lai J, Campbell IG, Chenevix-Trench G. Mutation and expression analysis of LZTS1 in ovarian cancer. Cancer Letters. 233: 151-7. PMID 15876481 DOI: 10.1016/j.canlet.2005.03.008  0.246
2019 Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, ... Campbell I, et al. Shared heritability and functional enrichment across six solid cancers. Nature Communications. 10: 431. PMID 30683880 DOI: 10.1038/S41467-018-08054-4  0.246
2018 Campbell I, Li N, Rowley S, Goode D, Devereux L, McInerny S, Grewal N, Lee A, Trainer A, Wong-Brown M, Scott R, Gorringe K, James P. Abstract PD1-04: The contribution of rare variants, polygenic risk, and novel candidate genes to the hereditary risk of breast cancer in a large cohort of breast cancer families Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd1-04  0.245
2001 Baxter SW, Choong DYH, Eccles DM, Campbell IG. Polymorphic variation in CYP19 and the risk of breast cancer Carcinogenesis. 22: 347-349. PMID 11181459 DOI: 10.1093/CARCIN/22.2.347  0.245
2020 Barnes DR, Rookus MA, McGuffog L, Leslie G, Mooij TM, Dennis J, Mavaddat N, Adlard J, Ahmed M, Aittomäki K, Andrieu N, Andrulis IL, Arnold N, Arun BK, Azzollini J, ... Campbell I, et al. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 32665703 DOI: 10.1038/S41436-020-0862-X  0.245
2014 Seneviratne S, Campbell I, Scott N, Shirley R, Peni T, Lawrenson R. Accuracy and completeness of the New Zealand Cancer Registry for staging of invasive breast cancer. Cancer Epidemiology. 38: 638-44. PMID 25037979 DOI: 10.1016/j.canep.2014.06.008  0.245
2008 Gorringe KL, Choong DY, Williams LH, Ramakrishna M, Sridhar A, Qiu W, Bearfoot JL, Campbell IG. Mutation and methylation analysis of the chromodomain-helicase-DNA binding 5 gene in ovarian cancer. Neoplasia (New York, N.Y.). 10: 1253-8. PMID 18953434 DOI: 10.1593/neo.08718  0.245
2018 Nickson C, Procopio P, Devereux L, Carr S, Mann G, Arzhaeva Y, Velentzis L, James P, Campbell I. Prospective Validation of the NCI Breast Cancer Risk Assessment Tool and the Autodensity Mammographic Density Tool on 40,000 Australian Screening Program Participants Journal of Global Oncology. 4: 49s-49s. DOI: 10.1200/JGO.18.20200  0.244
2016 Vigorito E, Kuchenbaecker KB, Beesley J, Adlard J, Agnarsson BA, Andrulis IL, Arun BK, Barjhoux L, Belotti M, Benitez J, Berger A, Bojesen A, Bonanni B, Brewer C, Caldes T, ... Campbell I, et al. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Plos One. 11: e0158801. PMID 27463617 DOI: 10.1371/Journal.Pone.0158801  0.242
2010 Antill YC, Mitchell G, Johnson SA, Devereux L, Milner A, Di Iulio J, Lindeman GJ, Kirk J, Phillips KA, Campbell IG. Gene methylation in breast ductal fluid from BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 265-74. PMID 20056647 DOI: 10.1158/1055-9965.EPI-09-0359  0.241
2015 Campbell I, Scott N, Seneviratne S, Kollias J, Walters D, Taylor C, Roder D. Breast cancer characteristics and survival differences between Maori, Pacific and other New Zealand women included in the Quality Audit program of Breast Surgeons of Australia and New Zealand. Asian Pacific Journal of Cancer Prevention : Apjcp. 16: 2465-72. PMID 25824782  0.241
2018 Li N, Rowley SM, Goode DL, Amarasinghe KC, McInerny S, Devereux L, Wong-Brown MW, Lupat R, Lee JEA, Hughes S, Thompson ER, Zethoven M, Li J, Trainer AH, ... ... Campbell IG, et al. Mutations in RECQL are not associated with breast cancer risk in an Australian population. Nature Genetics. PMID 30224651 DOI: 10.1038/s41588-018-0206-9  0.241
2017 Campbell I, Trainer A, Devereux L, James P, Rowley S, Li N. Abstract P2-02-01: Identifying the remaining causes of hereditary breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P2-02-01  0.24
2012 Beesley J, Pickett H, Johnatty S, Chen X, Li JJ, Rider D, Stutz M, Lambrecht D, Chang-Claude J, Dork T, Goodman M, Kiemmney B, Bandera E, Kelemen L, Wang-Gorke S, ... Campbell I, et al. Functional polymorphisms in the TERT promoter are associated with risk of serious ovarian and breast cancer Hereditary Cancer in Clinical Practice. 10: 1-2. DOI: 10.1186/1897-4287-10-S2-A86  0.24
2008 Campbell IG, Qiu W, Polyak K, Haviv I. Breast-cancer stromal cells with TP53 mutations. The New England Journal of Medicine. 358: 1634-5; author reply. PMID 18403774 DOI: 10.1056/NEJMc086024  0.24
1996 Campbell IG, Eccles DM, Dunn B, Davis M, Leake V. p53 polymorphism in ovarian and breast cancer. Lancet (London, England). 347: 393-4. PMID 8598715 DOI: 10.1016/S0140-6736(96)90569-3  0.24
2015 Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Campbell IG, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185  0.24
2005 Montgomery KG, Chang JH, Gertig DM, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG. The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women. Breast Cancer Research : Bcr. 7: R353-6. PMID 15987430 DOI: 10.1186/bcr1009  0.239
2012 Ooi CW, Campbell ID, Kollias J, de Silva P. National Breast Cancer Audit: overview of invasive breast cancer in New Zealand. The New Zealand Medical Journal. 125: 7-16. PMID 22932509  0.239
2021 Abrahimi MS, Elwood M, Lawrenson R, Campbell I, Tin Tin S. Associated Factors and Survival Outcomes for Breast Conserving Surgery versus Mastectomy among New Zealand Women with Early-Stage Breast Cancer. International Journal of Environmental Research and Public Health. 18. PMID 33800387 DOI: 10.3390/ijerph18052738  0.239
2017 Lecarpentier J, Silvestri V, Kuchenbaecker KB, Barrowdale D, Dennis J, McGuffog L, Soucy P, Leslie G, Rizzolo P, Navazio AS, Valentini V, Zelli V, Lee A, Amin Al Olama A, Tyrer JP, ... Campbell I, et al. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016694935. PMID 28448241 DOI: 10.1200/Jco.2016.69.4935  0.238
2008 Bearfoot JL, Choong DY, Gorringe KL, Campbell IG. Genetic analysis of cancer-implicated MicroRNA in ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7246-50. PMID 19010840 DOI: 10.1158/1078-0432.CCR-08-1348  0.238
2019 Kader T, Hill P, Zethoven M, Goode DL, Elder K, Thio N, Doyle M, Semple T, Sufyan W, Byrne DJ, Pang JB, Murugasu A, Miligy IM, Green AR, Rakha EA, ... ... Campbell IG, et al. Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma. The Journal of Pathology. PMID 30843206 DOI: 10.1002/path.5262  0.238
2016 Gorringe K, Hunter S, Byrne D, Devereux L, Rowley S, Elder K, Huynh R, Pridmore V, Hopper J, Kavanagh A, Mitchell G, Mann B, Fox S, Campbell I. Abstract P6-02-04: Screen detected and interval cancers; genomic analysis points to different molecular etiology? Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-02-04  0.237
2014 Campbell ID, Scott N, Seneviratne S, Kollias J, Walters D, Taylor C, Webster F, Zorbas H, Roder DM. Breast cancer survival in New Zealand women. Anz Journal of Surgery. PMID 25266995 DOI: 10.1111/ans.12851  0.237
2015 Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, ... ... Campbell IG, et al. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). Journal of Genetics and Genome Research. 2. PMID 26807442  0.237
2015 Huang KT, Mikeska T, Li J, Takano EA, Millar EK, Graham PH, Boyle SE, Campbell IG, Speed TP, Dobrovic A, Fox SB. Assessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumour. Bmc Cancer. 15: 669. PMID 26452468 DOI: 10.1186/s12885-015-1676-0  0.236
2021 Li N, Lim BWX, Thompson ER, McInerny S, Zethoven M, Cheasley D, Rowley SM, Wong-Brown MW, Devereux L, Gorringe KL, Sloan EK, Trainer A, Scott RJ, James PA, Campbell IG. Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study. Npj Breast Cancer. 7: 76. PMID 34117267 DOI: 10.1038/s41523-021-00279-9  0.236
1997 Manolitsas TP, Englefield P, Eccles DM, Campbell IG. No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer [2] British Journal of Cancer. 75: 1398-1399. PMID 9155067 DOI: 10.1038/Bjc.1997.238  0.236
2022 Scott OW, Tin Tin S, Elwood JM, Cavadino A, Habel LA, Kuper-Hommel M, Campbell I, Lawrenson R. Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study. Breast Cancer Research and Treatment. PMID 35286523 DOI: 10.1007/s10549-022-06528-0  0.235
2020 Lao C, Kuper-Hommel M, Elwood M, Campbell I, Edwards M, Lawrenson R. Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand. Breast Cancer (Tokyo, Japan). PMID 33044617 DOI: 10.1007/s12282-020-01171-3  0.235
2016 Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, ... Campbell I, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. PMID 27595995 DOI: 10.1136/jmedgenet-2016-103839  0.234
2020 Aye PS, Scott OW, Elwood JM, Sarfati D, Lawrenson R, Campbell ID, Kuper-Hommel M, Tin Tin S. Use of Non-Cancer Medications in New Zealand Women at the Diagnosis of Primary Invasive Breast Cancer: Prevalence, Associated Factors and Effects on Survival. International Journal of Environmental Research and Public Health. 17. PMID 33138255 DOI: 10.3390/ijerph17217962  0.233
2000 Campbell IG, Manolitsas T. Absence of PPP2R1B gene alterations in primary ovarian cancers. Oncogene. 18: 6367-9. PMID 10597236 DOI: 10.1038/sj.onc.1203070  0.233
2013 Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Ziogas A, Zheng W, Yang HP, ... ... Campbell I, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 4: 1628. PMID 23535649 DOI: 10.1038/Ncomms2629  0.233
2017 Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Bogdanova N, Brinton L, Butzow R, Campbell I, Carty K, Chang-Claude J, Cook LS, et al. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. British Journal of Cancer. PMID 28103614 DOI: 10.1038/Bjc.2016.426  0.233
2022 Li N, Zethoven M, McInerny S, Healey E, DeSilva D, Devereux L, Scott RJ, James PA, Campbell IG. Contribution of large genomic rearrangements in to familial breast cancer: implications for genetic testing. Journal of Medical Genetics. PMID 35396271 DOI: 10.1136/jmedgenet-2021-108399  0.233
2010 Thompson E, Ellul J, Li J, Doyle M, Campbell I. Abstract LB-184: Identification of breast cancer susceptibility genes using whole exome sequencing Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-184  0.232
2018 Latt PM, Tin Tin S, Elwood M, Lawrenson R, Campbell I. Receipt of radiotherapy after mastectomy in women with breast cancer: Population-based cohort study in New Zealand. Asia-Pacific Journal of Clinical Oncology. PMID 30430744 DOI: 10.1111/ajco.13101  0.232
2014 Roder D, Zorbas HM, Kollias J, Pyke CM, Walters D, Campbell ID, Taylor C, Webster F. Analysing risk factors for poorer breast cancer outcomes in residents of lower socioeconomic areas of Australia. Australian Health Review : a Publication of the Australian Hospital Association. 38: 134-41. PMID 24709287 DOI: 10.1071/AH13080  0.232
2021 Lao C, Kuper-Hommel M, Campbell I, Elwood M, Lawrenson R. Use and results of systemic treatments for de novo and recurrent metastatic breast cancer: a population-based cohort study. The New Zealand Medical Journal. 134: 47-59. PMID 34788271  0.232
2007 Liu MC, Choong DY, Hooi CS, Williams LH, Campbell IG. Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer. Cancer Letters. 247: 91-7. PMID 16644110 DOI: 10.1016/j.canlet.2006.03.024  0.23
2017 Lawrenson R, Lao C, Campbell I, Harvey V, Brown C, Seneviratne S, Edwards M, Elwood M, Kuper-Hommel M. The use of trastuzumab in New Zealand women with breast cancer. Asia-Pacific Journal of Clinical Oncology. PMID 28856817 DOI: 10.1111/ajco.12766  0.23
2021 Lao C, Kuper-Hommel M, Elwood M, Campbell I, Lawrenson R. Metastatic relapse of stage I-III breast cancer in New Zealand. Cancer Causes & Control : Ccc. PMID 33830387 DOI: 10.1007/s10552-021-01426-0  0.23
2022 Lao C, Mondal M, Kuper-Hommel M, Campbell I, Lawrenson R. What affects the public healthcare costs of breast cancer in New Zealand? Asia-Pacific Journal of Clinical Oncology. PMID 36114604 DOI: 10.1111/ajco.13844  0.23
2003 Campbell IG, Allen J, Eccles DM. Prohibitin 3′ Untranslated Region Polymorphism and Breast Cancer Risk Cancer Epidemiology Biomarkers and Prevention. 12: 1273-1274. PMID 14652295  0.229
2014 Seneviratne S, Campbell I, Scott N, Kuper-Hommel M, Round G, Lawrenson R. Ethnic differences in timely adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand: a cohort study. Bmc Cancer. 14: 839. PMID 25406582 DOI: 10.1186/1471-2407-14-839  0.229
2022 Lao C, Mondal M, Kuper-Hommel M, Campbell I, Lawrenson R. Differences in Breast Cancer Costs by Cancer Stage and Biomarker Subtype in New Zealand. Pharmacoeconomics - Open. PMID 35184273 DOI: 10.1007/s41669-022-00327-5  0.229
2002 Bryan EJ, Jokubaitis VJ, Chamberlain NL, Baxter SW, Dawson E, Choong DY, Campbell IG. Mutation analysis of EP300 in colon, breast and ovarian carcinomas. International Journal of Cancer. 102: 137-41. PMID 12385008 DOI: 10.1002/ijc.10682  0.228
2018 Campbell I, Lao C, Blackmore T, Edwards M, Hayes L, Ng A, Lawrenson R. Surgical treatment of early stage breast cancer in the Auckland and Waikato regions of New Zealand. Anz Journal of Surgery. PMID 30253442 DOI: 10.1111/ans.14840  0.228
2015 Seneviratne S, Campbell I, Scott N, Coles C, Lawrenson R. Treatment delay for Māori women with breast cancer in New Zealand. Ethnicity & Health. 20: 178-93. PMID 24635721 DOI: 10.1080/13557858.2014.895976  0.228
2013 Roder D, Zorbas H, Kollias J, Pyke C, Walters D, Campbell I, Taylor C, Webster F. Risk factors for poorer breast cancer outcomes in residents of remote areas of Australia. Asian Pacific Journal of Cancer Prevention : Apjcp. 14: 547-52. PMID 23534792 DOI: 10.7314/APJCP.2013.14.1.547  0.228
2017 Seneviratne S, Campbell I, Scott N, Lawrenson R. A cohort study of ethnic differences in use of adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand. Bmc Health Services Research. 17: 64. PMID 28109301 DOI: 10.1186/s12913-017-2027-4  0.227
2015 Seneviratne S, Lawrenson R, Scott N, Kim B, Shirley R, Campbell I. Breast cancer biology and ethnic disparities in breast cancer mortality in new zealand: a cohort study. Plos One. 10: e0123523. PMID 25849101 DOI: 10.1371/journal.pone.0123523  0.227
2018 Qian F, Wang S, Mitchell J, McGuffog L, Barrowdale D, Leslie G, Oosterwijk JC, Chung WK, Evans DG, Engel C, Kast K, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, ... Campbell I, et al. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. Journal of the National Cancer Institute. PMID 30312457 DOI: 10.1093/jnci/djy132  0.227
2017 Lawrenson R, Lao C, Campbell I, Harvey V, Seneviratne S, Edwards M, Elwood M, Scott N, Kidd J, Sarfati D, Kuper-Hommel M. Treatment and survival disparities by ethnicity in New Zealand women with stage I-III breast cancer tumour subtypes. Cancer Causes & Control : Ccc. PMID 29027594 DOI: 10.1007/s10552-017-0969-9  0.226
2015 Seneviratne S, Campbell I, Scott N, Shirley R, Lawrenson R. Impact of mammographic screening on ethnic and socioeconomic inequities in breast cancer stage at diagnosis and survival in New Zealand: a cohort study. Bmc Public Health. 15: 46. PMID 25637343 DOI: 10.1186/s12889-015-1383-4  0.226
2016 Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK, Lee JM, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, ... Campbell I, et al. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature Communications. 7: 12675. PMID 27601076 DOI: 10.1038/ncomms12675  0.225
2023 Fierheller CT, Alenezi WM, Serruya C, Revil T, Amuzu S, Bedard K, Subramanian DN, Fewings E, Bruce JP, Prokopec S, Bouchard L, Provencher D, Foulkes WD, El Haffaf Z, Mes-Masson AM, ... ... Campbell IG, et al. Molecular Genetic Characteristics of , a Proposed New Ovarian Cancer Predisposing Gene. Genes. 14. PMID 36833203 DOI: 10.3390/genes14020277  0.225
2024 Barnes DR, Tyrer JP, Dennis J, Leslie G, Bolla MK, Lush M, Aeilts AM, Aittomäki K, Andrieu N, Andrulis IL, Anton-Culver H, Arason A, Arun BK, Balmaña J, Bandera EV, ... ... Campbell I, et al. Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk. Medrxiv : the Preprint Server For Health Sciences. PMID 38496424 DOI: 10.1101/2024.02.29.24303243  0.225
2020 Song H, Dicks EM, Tyrer J, Intermaggio M, Chenevix-Trench G, Bowtell DD, Traficante N, Group A, Brenton J, Goranova T, Hosking K, Piskorz A, van Oudenhove E, Doherty J, Harris HR, ... ... Campbell IG, et al. Population-based targeted sequencing of 54 candidate genes identifies as a susceptibility gene for high-grade serous ovarian cancer. Journal of Medical Genetics. PMID 32546565 DOI: 10.1136/Jmedgenet-2019-106739  0.224
2015 Thompson ER, Gorringe KL, Rowley SM, Wong-Brown MW, McInerny S, Li N, Trainer AH, Devereux L, Doyle MA, Li J, Lupat R, Delatycki MB, Mitchell G, James PA, Scott RJ, ... Campbell IG, et al. Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls Breast Cancer Research. 17. DOI: 10.1186/s13058-015-0627-7  0.224
1999 Wang ZJ, Churchman M, Campbell IG, Xu WH, Yan ZY, McCluggage WG, Foulkes WD, Tomlinson IP. Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours. British Journal of Cancer. 80: 70-2. PMID 10389980 DOI: 10.1038/sj.bjc.6690323  0.224
2001 Baxter SW, Campbell IG. Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. Journal of the National Cancer Institute. 93: 557-9. PMID 11287454 DOI: 10.1093/JNCI/93.7.557  0.223
2016 Zeng C, Guo X, Long J, Kuchenbaecker KB, Droit A, Michailidou K, Ghoussaini M, Kar S, Freeman A, Hopper JL, Milne RL, Bolla MK, Wang Q, Dennis J, Agata S, ... Campbell I, et al. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Breast Cancer Research : Bcr. 18: 64. PMID 27459855 DOI: 10.1186/S13058-016-0718-0  0.223
2018 Tin Tin S, Elwood JM, Brown C, Sarfati D, Campbell I, Scott N, Ramsaroop R, Seneviratne S, Harvey V, Lawrenson R. Ethnic disparities in breast cancer survival in New Zealand: which factors contribute? Bmc Cancer. 18: 58. PMID 29310606 DOI: 10.1186/s12885-017-3797-0  0.222
2001 Thomas NA, Choong DY, Jokubaitis VJ, Neville PJ, Campbell IG. Mutation of the ST7 tumor suppressor gene on 7q31.1 is rare in breast, ovarian and colorectal cancers. Nature Genetics. 29: 379-80. PMID 11726923 DOI: 10.1038/ng784  0.222
2015 Seneviratne S, Campbell I, Scott N, Kuper-Hommel M, Kim B, Pillai A, Lawrenson R. Adherence to adjuvant endocrine therapy: is it a factor for ethnic differences in breast cancer outcomes in New Zealand? Breast (Edinburgh, Scotland). 24: 62-7. PMID 25486877 DOI: 10.1016/j.breast.2014.11.011  0.222
2018 Nickson C, Procopio P, Velentzis LS, Carr S, Devereux L, Mann GB, James P, Lee G, Wellard C, Campbell I. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women. Breast Cancer Research : Bcr. 20: 155. PMID 30572910 DOI: 10.1186/S13058-018-1084-X  0.222
2015 Seneviratne S, Campbell I, Scott N, Shirley R, Peni T, Lawrenson R. Ethnic differences in breast cancer survival in New Zealand: contributions of differences in screening, treatment, tumor biology, demographics and comorbidities. Cancer Causes & Control : Ccc. 26: 1813-24. PMID 26407955 DOI: 10.1007/s10552-015-0674-5  0.222
2017 Pang JB, Savas P, Fellowes AP, Mir Arnau G, Kader T, Vedururu R, Hewitt C, Takano EA, Byrne DJ, Choong DY, Millar EK, Lee CS, O'Toole SA, Lakhani SR, Cummings MC, ... ... Campbell IG, et al. Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 28338653 DOI: 10.1038/modpathol.2017.21  0.221
2000 Bryan EJ, Thomas NA, Palmer K, Dawson E, Englefield P, Campbell IG. Refinement of an ovarian cancer tumour suppressor gene locus on chromosome arm 22q and mutation analysis of CYP2D6, SREBP2 and NAGA. International Journal of Cancer. 87: 798-802. PMID 10956388 DOI: 10.1002/1097-0215(20000915)87:6<798::AID-IJC6>3.0.CO;2-X  0.221
2006 Rudenstam CM, Zahrieh D, Forbes JF, Crivellari D, Holmberg SB, Rey P, Dent D, Campbell I, Bernhard J, Price KN, Castiglione-Gertsch M, Goldhirsch A, Gelber RD, Coates AS. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 337-44. PMID 16344321 DOI: 10.1200/JCO.2005.01.5784  0.221
2013 Campbell I, Hunter S, Mathew W, Antill Y, Bae S, Ananda S, Topp M, Lipton L, Liauw W, Jobling T, Boussioutas A, Christie M, Allan P, Friedlander M, Fox S, et al. Abstract A3: Mucinous ovarian tumors: Are they all the same? Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A3  0.221
2013 White KL, Vierkant RA, Fogarty ZC, Charbonneau B, Block MS, Pharoah PD, Chenevix-Trench G, Rossing MA, Cramer DW, Pearce CL, Schildkraut JM, Menon U, Kjaer SK, Levine DA, ... ... Campbell I, et al. Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 987-92. PMID 23513043 DOI: 10.1158/1055-9965.Epi-13-0028  0.22
2001 Baxter SW, Thomas EJ, Campbell IG. GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer. Carcinogenesis. 22: 63-5. PMID 11159742 DOI: 10.1093/CARCIN/22.1.63  0.22
2015 Seneviratne S, Scott N, Lawrenson R, Campbell I. Ethnic, socio-demographic and socio-economic differences in surgical treatment of breast cancer in New Zealand. Anz Journal of Surgery. PMID 25707555 DOI: 10.1111/ans.13011  0.22
2012 Roder DM, de Silva P, Zorbas HM, Kollias J, Malycha PL, Pyke CM, Campbell ID. Age effects on survival from early breast cancer in clinical settings in Australia Anz Journal of Surgery. 82: 524-528. PMID 22776502 DOI: 10.1111/j.1445-2197.2012.06114.x  0.219
2015 Chornokur G, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai YY, Jim HS, Chen Z, Chen AY, Permuth-Wey J, Aben KKh, Anton-Culver H, Antonenkova N, ... ... Campbell IG, et al. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. Plos One. 10: e0128106. PMID 26091520 DOI: 10.1371/Journal.Pone.0128106  0.219
2007 Antill YC, Mitchell G, Johnson SA, Devereux L, Milner A, Sridhar A, Kirk JA, Phillips K, Lindeman G, Campbell IG. Predicting breast cancer risk in BRCA1 and BRCA2 carriers: Methylation studies using intraductal fluid Journal of Clinical Oncology. 25: 10537-10537. DOI: 10.1200/JCO.2007.25.18_SUPPL.10537  0.219
2020 Fachal L, Aschard H, Beesley J, Barnes DR, Allen J, Kar S, Pooley KA, Dennis J, Michailidou K, Turman C, Soucy P, Lemaçon A, Lush M, Tyrer JP, Ghoussaini M, ... ... Campbell I, et al. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nature Genetics. PMID 31911677 DOI: 10.1038/s41588-019-0537-1  0.219
2023 Bartholomew K, Ghafel M, Tin Tin S, Aye PS, Elwood JM, Hardie C, Scott N, Kidd J, Ramsaroop R, Campbell I. Receipt of mastectomy and adjuvant radiotherapy following breast conserving surgery (BCS) in New Zealand women with BCS-eligible breast cancer, 2010-2015: an observational study focusing on ethnic differences. Bmc Cancer. 23: 766. PMID 37592208 DOI: 10.1186/s12885-023-11248-9  0.219
2022 James PA, Fortuno C, Li N, Lim BWX, Campbell IG, Spurdle AB. Estimating the proportion of pathogenic variants from breast cancer case-control data: application to calibration of ACMG/AMP variant classification criteria. Human Mutation. PMID 35191126 DOI: 10.1002/humu.24357  0.218
2012 Roder D, De Silva P, Zorbas HM, Kollias J, Malycha PL, Pyke CM, Campbell ID. Survival from breast cancer: An analysis of Australian data by surgeon case load, treatment centre location, and health insurance status Australian Health Review. 36: 342-348. PMID 22935129 DOI: 10.1071/AH11060  0.218
2003 Montgomery KG, Gertig DM, Baxter SW, Milne RL, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG. The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 1109-11. PMID 14578152  0.218
2013 Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... ... Campbell I, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566  0.218
2012 Roder DM, de Silva P, Zorbas HN, Webster F, Kollias J, Pyke CM, Campbell ID. Adherence to recommended treatments for early invasive breast cancer: Decisions of women attending surgeons in the breast cancer audit of Australia and New Zealand Asian Pacific Journal of Cancer Prevention. 13: 1675-1682. PMID 22799387 DOI: 10.7314/APJCP.2012.13.4.1675  0.218
2024 Lawrenson R, Lao C, Stanley J, Teng A, Kuper-Hommel M, Campbell I, Krebs J, Sika-Paotonu D, Koea J, Meredith I, Gurney J. Does diabetes affect breast cancer survival? Cancer Reports (Hoboken, N.J.). 7: e2040. PMID 38507264 DOI: 10.1002/cnr2.2040  0.217
2018 Lawrenson R, Lao C, Campbell I, Harvey V, Seneviratne S, Elwood M, Sarfati D, Kuper-Hommel M. The impact of different tumour subtypes on management and survival of New Zealand women with Stage I-III breast cancer. The New Zealand Medical Journal. 131: 51-60. PMID 29771902  0.217
2023 De Silva DL, Stafford L, Skandarajah AR, Sinclair M, Devereux L, Hogg K, Kentwell M, Park A, Lal L, Zethoven M, Jayawardana MW, Chan F, Butow PN, James PA, Mann GB, ... Campbell IG, et al. Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care. The Medical Journal of Australia. PMID 37005005 DOI: 10.5694/mja2.51906  0.216
2010 Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, ... ... Campbell I, et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nature Genetics. 42: 874-9. PMID 20852632 DOI: 10.1038/Ng.668  0.216
2007 Gorringe KL, Jacobs S, Thompson ER, Sridhar A, Qiu W, Choong DY, Campbell IG. High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 4731-9. PMID 17699850 DOI: 10.1158/1078-0432.CCR-07-0502  0.215
1998 Morland SJ, Jiang X, Hitchcock A, Thomas EJ, Campbell IG. Mutation of galactose-1-phosphate uridyl transferase and its association with ovarian cancer and endometriosis. International Journal of Cancer. 77: 825-7. PMID 9714048 DOI: 10.1002/(SICI)1097-0215(19980911)77:6<825::AID-IJC4>3.0.CO;2-W  0.215
2021 Barnes DR, Silvestri V, Leslie G, McGuffog L, Dennis J, Yang X, Adlard J, Agnarsson BA, Ahmed M, Aittomäki K, Andrulis IL, Arason A, Arnold N, Auber B, Azzollini J, ... Campbell I, et al. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores. Journal of the National Cancer Institute. PMID 34320204 DOI: 10.1093/jnci/djab147  0.215
2011 Beesley J, Pickett HA, Johnatty SE, Dunning AM, Chen X, Li J, Michailidou K, Lu Y, Rider DN, Palmieri RT, Stutz MD, Lambrechts D, Despierre E, Lambrechts S, Vergote I, ... ... Campbell I, et al. Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. Plos One. 6: e24987. PMID 21949822 DOI: 10.1371/Journal.Pone.0024987  0.215
2010 Byron SA, Gartside MG, Wellens CL, Goodfellow PJ, Birrer MJ, Campbell IG, Pollock PM. FGFR2 mutations are rare across histologic subtypes of ovarian cancer. Gynecologic Oncology. 117: 125-9. PMID 20106510 DOI: 10.1016/J.Ygyno.2009.12.002  0.215
2020 Blackmore T, Del Mundo-Ramos E, Chepulis L, Lao C, Burrett V, McCleery J, Campbell I, Lawrenson R. Psychosocial Support Needs of Women with Breast Cancer in the Waikato Region of New Zealand. Psycho-Oncology. PMID 32779221 DOI: 10.1002/pon.5510  0.214
2014 Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeney LA, Baglietto L, Giles GG, ... Campbell I, et al. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Research. 74: 852-61. PMID 24272484 DOI: 10.1158/0008-5472.Can-13-1051  0.214
2019 Lao C, Lawrenson R, Edwards M, Campbell I. Treatment and survival of Asian women diagnosed with breast cancer in New Zealand. Breast Cancer Research and Treatment. PMID 31168758 DOI: 10.1007/s10549-019-05310-z  0.214
2015 Ryland GL, Doyle MA, Goode D, Boyle SE, Choong DY, Rowley SM, Li J, Bowtell DD, Tothill RW, Campbell IG, Gorringe KL. Loss of heterozygosity: what is it good for? Bmc Medical Genomics. 8: 45. PMID 26231170 DOI: 10.1186/s12920-015-0123-z  0.213
2011 Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS, Beckmann MW, Birrer MJ, Bogdanova N, Bolton KL, ... ... Campbell I, et al. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3742-50. PMID 21385923 DOI: 10.1158/1078-0432.Ccr-10-3405  0.212
2013 Roder D, Zorbas H, Kollias J, Pyke C, Walters D, Campbell I, Taylor C, Webster F. Factors predictive of treatment by Australian breast surgeons of invasive female breast cancer by mastectomy rather than breast conserving surgery. Asian Pacific Journal of Cancer Prevention : Apjcp. 14: 539-45. PMID 23534791 DOI: 10.7314/APJCP.2013.14.1.539  0.212
2022 Lim BWX, Li N, Rowley SM, Thompson ER, McInerny S, Zethoven M, Scott RJ, Devereux L, Sloan EK, James PA, Campbell IG. Integration of tumour sequencing and case-control data to assess pathogenicity of RAD51C missense variants in familial breast cancer. Npj Breast Cancer. 8: 10. PMID 35039523 DOI: 10.1038/s41523-021-00373-y  0.212
2016 Dixon SC, Nagle CM, Thrift AP, Pharoah PD, Pearce CL, Zheng W, Painter JN, Chenevix-Trench AG, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, ... Campbell I, et al. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology. PMID 27401727 DOI: 10.1093/Ije/Dyw158  0.21
2013 Trapani JA, Thia KY, Andrews M, Davis ID, Gedye C, Parente P, Svobodova S, Chia J, Browne K, Campbell IG, Phillips WA, Voskoboinik I, Cebon JS. Human perforin mutations and susceptibility to multiple primary cancers. Oncoimmunology. 2: e24185. PMID 23734337 DOI: 10.4161/onci.24185  0.209
2023 Dempsey K, Mathieu E, Brennan M, Snook K, Hoffman J, Campbell I, Scarlet J, Flay H, Wong A, Boyle F, King M, Spillane A. Patient-reported health-related quality of life outcomes following mastectomy for breast cancer, with immediate, delayed or no breast reconstruction: Four-year follow-up from a prospective cohort study. Breast (Edinburgh, Scotland). 71: 122-131. PMID 37573653 DOI: 10.1016/j.breast.2023.08.001  0.209
2015 Johnatty S, Tyrer JP, Kar SP, Beesley J, Lu Y, Gao B, Fasching PA, Hein A, Ekici AB, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambrechts S, Rossing MA, ... Campbell I, et al. Genome-wide analysis identifies novel loci associated with ovarian cancer outcomes: findings from the Ovarian Cancer Association Consortium. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26152742 DOI: 10.1158/1078-0432.Ccr-15-0632  0.208
2012 Chew GL, Huang D, Lin SJ, Huo C, Blick T, Henderson MA, Hill P, Cawson J, Morrison WA, Campbell IG, Hopper JL, Southey MC, Haviv I, Thompson EW. High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers. Breast Cancer Research and Treatment. 135: 177-87. PMID 22729891 DOI: 10.1007/s10549-012-2128-z  0.206
2020 Cheasley D, Nigam A, Zethoven M, Hunter S, Etemadmoghadam D, Semple T, Allan P, Carey MS, Fernandez ML, Dawson A, Köbel M, Huntsman DG, Page CL, Mes-Masson AM, Provencher D, ... ... Campbell IG, et al. Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities. The Journal of Pathology. PMID 32901952 DOI: 10.1002/path.5545  0.204
2018 Lawrenson R, Lao C, Ali A, Campbell I. Impact of radiotherapy on cardiovascular health of women with breast cancer. Journal of Medical Imaging and Radiation Oncology. PMID 30556371 DOI: 10.1111/1754-9485.12838  0.204
1995 Campbell IG, Foulkes WD, Beynon G, Davis M, Englefield P. LOH and mutation analysis of CDKN2 in primary human ovarian cancers. International Journal of Cancer. 63: 222-5. PMID 7591208 DOI: 10.1002/IJC.2910630213  0.203
2023 Alenezi WM, Fierheller CT, Serruya C, Revil T, Oros KK, Subramanian DN, Bruce J, Spiegelman D, Pugh T, Campbell IG, Mes-Masson AM, Provencher D, Foulkes WD, Haffaf ZE, Rouleau G, et al. Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases. Frontiers in Oncology. 13: 1111191. PMID 36969007 DOI: 10.3389/fonc.2023.1111191  0.203
2000 Thomas EJ, Campbell IG. Evidence that endometriosis behaves in a malignant manner Gynecologic and Obstetric Investigation. 50: 2-10. PMID 11093055 DOI: 10.1159/000052872  0.203
2002 Baxter SW, Choong DYH, Eccles DM, Campbell IG. Transforming growth factor β receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer Cancer Epidemiology Biomarkers and Prevention. 11: 211-214. PMID 11867510  0.203
2006 Hooi CF, Blancher C, Qiu W, Revet IM, Williams LH, Ciavarella ML, Anderson RL, Thompson EW, Connor A, Phillips WA, Campbell IG. ST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrix. Oncogene. 25: 3924-33. PMID 16474848 DOI: 10.1038/sj.onc.1209418  0.202
2016 Sucheston-Campbell LE, Cannioto R, Clay AI, Etter JL, Eng KH, Liu S, Battaglia S, Hu Q, Szender JB, Minlikeeva A, Joseph J, Mayor P, Abrams SI, Segal B, Wallace PK, ... ... Campbell IG, et al. No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27677730 DOI: 10.1158/1055-9965.Epi-16-0631  0.202
2011 Campbell I, Qiu W, Haviv I. Genetic changes in tumour microenvironments The Journal of Pathology. 223: 450-458. PMID 21294119 DOI: 10.1002/Path.2842  0.202
2010 Arnold JM, Choong DY, Thompson ER, Waddell N, Lindeman GJ, Visvader JE, Campbell IG, Chenevix-Trench G. Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors. Breast Cancer Research and Treatment. 119: 491-6. PMID 19189213 DOI: 10.1007/s10549-008-0269-x  0.202
2013 Mitchell G, Campbell I, Dawkins H, Fox S, Hiller J, James P, Kirk J, Lindeman G, Macrae F, McGaughran J, Meiser B, Pachter N, Saunders C, Scott C, Suthers G, et al. An Introduction to ICCon - Inherited Cancer Connect Partnership Asia-Pacific Journal of Clinical Oncology. 9: 113-113. DOI: 10.1111/Ajco.12145  0.201
2015 Lee AW, Tyrer JP, Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Spiewankiewicz B, Myers EJ, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, ... ... Campbell IG, et al. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. Gynecologic Oncology. 136: 542-8. PMID 25528498 DOI: 10.1016/J.Ygyno.2014.12.017  0.201
2017 Edwards MJ, Campbell ID, Lawrenson RA, Kuper-Hommel MJ. Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis. Breast Cancer Research and Treatment. PMID 28528451 DOI: 10.1007/s10549-017-4295-4  0.2
2017 Brown C, Lao C, Lawrenson R, Tin Tin S, Schaaf M, Kidd J, Allan-Moetaua A, Herman J, Raamsroop R, Campbell I, Elwood M. Characteristics of and differences between Pasifika women and New Zealand European women diagnosed with breast cancer in New Zealand. The New Zealand Medical Journal. 130: 50-61. PMID 29240740  0.2
2020 Kader T, Elder K, Zethoven M, Semple T, Hill P, Goode DL, Thio N, Cheasley D, Rowley SM, Byrne DJ, Pang JM, Miligy IM, Green AR, Rakha EA, Fox SB, ... ... Campbell IG, et al. The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma. Npj Breast Cancer. 6: 9. PMID 33574298 DOI: 10.1038/s41523-020-0150-6  0.2
2020 Kader T, Elder K, Zethoven M, Semple T, Hill P, Goode DL, Thio N, Cheasley D, Rowley SM, Byrne DJ, Pang JM, Miligy IM, Green AR, Rakha EA, Fox SB, ... ... Campbell IG, et al. The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma. Npj Breast Cancer. 6: 9. PMID 32195332 DOI: 10.1038/s41523-020-0150-6  0.2
2009 Gorringe KL, Campbell IG. Large-scale genomic analysis of ovarian carcinomas. Molecular Oncology. 3: 157-64. PMID 19383377 DOI: 10.1016/j.molonc.2008.12.005  0.2
2018 Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, ... Campbell I, et al. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. British Journal of Cancer. PMID 29555990 DOI: 10.1038/S41416-018-0011-3  0.2
2012 Asim M, Cham A, Banerjee S, Nancekivell R, Dutu G, McBride C, Cavanagh S, Lawrenson R, Campbell I. Difficulties with defining lymphoedema after axillary dissection for breast cancer. The New Zealand Medical Journal. 125: 29-39. PMID 22426609  0.2
2022 Lao C, Gurney J, Stanley J, Krebs J, Meredith I, Campbell I, Teng A, Sika-Paotonu D, Koea J, Lawrenson R. Association of diabetes and breast cancer characteristics at diagnosis. Cancer Causes & Control : Ccc. PMID 36409455 DOI: 10.1007/s10552-022-01654-y  0.2
2018 Lu Y, Beeghly-Fadiel A, Wu L, Guo X, Li B, Schildkraut JM, Im HK, Chen YA, Permuth JB, Reid BM, Teer JK, Moysich KB, Andrulis IL, Anton-Culver H, Arun BK, ... ... Campbell IG, et al. A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk. Cancer Research. PMID 30054336 DOI: 10.1158/0008-5472.Can-18-0951  0.199
2010 Gaire RK, Bailey J, Bearfoot J, Campbell IG, Stuckey PJ, Haviv I. MIRAGAA--a methodology for finding coordinated effects of microRNA expression changes and genome aberrations in cancer. Bioinformatics (Oxford, England). 26: 161-7. PMID 19933823 DOI: 10.1093/bioinformatics/btp654  0.199
2005 Kelemen L, James M, Spurdle A, Campbell I, Chang-Claude J, Peel D, Anton-Culver H, Berchuck A, Schildkraut J, Whittemore A, McGurie V, DiCioccio RA, Duffy D, Chenevix-Trench G. BRAF polymorphisms and the risk of ovarian cancer of low malignant potential. Gynecologic Oncology. 97: 807-12. PMID 15904951 DOI: 10.1016/J.Ygyno.2005.03.007  0.199
1994 Campbell IG, Nicolai HM, Foulkes WD, Senger G, Stamp GW, Allan G, Boyer C, Jones K, Bast RC, Solomon E. A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1. Human Molecular Genetics. 3: 589-94. PMID 8069304 DOI: 10.1093/Hmg/3.4.589  0.197
2014 James PA, Petelin L, Campbell I, Dawkins H, Fox S, Hiller J, Kirk J, Lindeman G, Macrae F, Mascarenhas L, McGaughran J, Meiser B, Morrow A, Nichols C, Pachter N, et al. The inherited cancer connect (iccon) mutation-carrier database Asia-Pacific Journal of Clinical Oncology. 10: 167-168. DOI: 10.1111/Ajco.12305  0.197
2015 Davis SJ, Sheppard KE, Anglesio MS, George J, Traficante N, Fereday S, Intermaggio MP, Menon U, Gentry-Maharaj A, Lubinski J, Gronwald J, Pearce CL, Pike MC, Wu A, Kommoss S, ... ... Campbell IG, et al. Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition. Molecular Cancer Therapeutics. 14: 1495-503. PMID 25852062 DOI: 10.1158/1535-7163.Mct-15-0039  0.197
2019 Grolleman JE, de Voer RM, Elsayed FA, Nielsen M, Weren RDA, Palles C, Ligtenberg MJL, Vos JR, Ten Broeke SW, de Miranda NFCC, Kuiper RA, Kamping EJ, Jansen EAM, Vink-Börger ME, Popp I, ... ... Campbell IG, et al. Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor Phenotype. Cancer Cell. 35: 256-266.e5. PMID 30753826 DOI: 10.1016/j.ccell.2018.12.011  0.197
2015 Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N, Baker H, ... ... Campbell IG, et al. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications. 6: 8234. PMID 26391404 DOI: 10.1038/Ncomms9234  0.196
2017 Thompson ER, Wong-Brown M, Rowley SM, Dooley S, Lil N, Hipwell M, McInerny S, Meldrum C, Devereux L, Mossman D, Trainer AH, Millar B, Mitchell G, Smith C, James PA, ... Campbell IG, et al. Meeting abstracts from the Annual Conference on Hereditary Cancers 2015 Hereditary Cancer in Clinical Practice. 15. DOI: 10.1186/s13053-017-0074-9  0.196
2007 Bennett H, Marshall R, Campbell I, Lawrenson R. Women with breast cancer in Aotearoa New Zealand: the effect of urban versus rural residence on stage at diagnosis and survival. The New Zealand Medical Journal. 120: U2831. PMID 18264200  0.196
2022 Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, Agata S, Andrulis IL, Anton-Culver H, Antonenkova NN, Aravantinos G, Arun BK, Augustinsson A, Balmaña J, ... ... Campbell I, et al. Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics : Ejhg. PMID 35027648 DOI: 10.1038/s41431-021-00987-7  0.196
2013 Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, ... ... Campbell I, et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics. 45: 362-70, 370e1-2. PMID 23535730 DOI: 10.1038/Ng.2564  0.196
2001 Campbell IG, Thomas EJ. Endometriosis: candidate genes. Human Reproduction Update. 7: 15-20. PMID 11212068 DOI: 10.1093/HUMUPD/7.1.15  0.195
2005 Campbell IG, Russell SE, Phillips WA. PIK3CA mutations in ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 7042; author reply 7. PMID 16203798 DOI: 10.1158/1078-0432.CCR-05-1024  0.195
2014 Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, ... ... Campbell IG, et al. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human Genetics. 133: 481-97. PMID 24190013 DOI: 10.1007/S00439-013-1383-3  0.195
2021 Fierheller CT, Guitton-Sert L, Alenezi WM, Revil T, Oros KK, Gao Y, Bedard K, Arcand SL, Serruya C, Behl S, Meunier L, Fleury H, Fewings E, Subramanian DN, Nadaf J, ... ... Campbell IG, et al. A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene. Genome Medicine. 13: 186. PMID 34861889 DOI: 10.1186/s13073-021-00998-5  0.194
2013 Davis SJ, Sheppard KE, Pearson RB, Campbell IG, Gorringe KL, Simpson KJ. Functional analysis of genes in regions commonly amplified in high-grade serous and endometrioid ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1411-21. PMID 23362323 DOI: 10.1158/1078-0432.CCR-12-3433  0.194
2015 Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix-Trench G, Baker H, Bandera E, Bean YT, Beckmann MW, Berchuck A, Bisogna M, Bjørge L, ... Campbell I, et al. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26209509 DOI: 10.1158/1055-9965.Epi-14-1270  0.193
2016 Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, ... ... Campbell IG, et al. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. PMID 27533245 DOI: 10.18632/Oncotarget.10215  0.193
2015 Takano EA, Hunter SM, Campbell IG, Fox SB. Low-grade fibromatosis-like spindle cell carcinomas of the breast are molecularly exiguous. Journal of Clinical Pathology. 68: 362-7. PMID 25713418 DOI: 10.1136/jclinpath-2014-202824  0.192
2018 Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, Anton-Culver H, Antonenkova N, Bandera EV, Bean YT, Beckmann MW, Bjorge L, Bogdanova N, Brinton LA, ... ... Campbell IG, et al. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. Plos One. 13: e0197561. PMID 29979793 DOI: 10.1371/Journal.Pone.0197561  0.192
2002 Baxter SW, Choong DY, Campbell IG. Microsomal epoxide hydrolase polymorphism and susceptibility to ovarian cancer. Cancer Letters. 177: 75-81. PMID 11809533 DOI: 10.1016/S0304-3835(01)00782-0  0.191
1998 Campbell I, Thomas E, Hitchcock A, Morland S, Jiang X. Endometriosis and ovarian cancer British Journal of Obstetrics and Gynaecology. 105: 1222-1222. DOI: 10.1111/J.1471-0528.1998.Tb09981_7.X  0.191
2010 Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Campbell I, et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 42: 880-4. PMID 20852633 DOI: 10.1038/Ng.666  0.191
2018 Elwood JM, Tin Tin S, Kuper-Hommel M, Lawrenson R, Campbell I. Obesity and breast cancer outcomes in chemotherapy patients in New Zealand - a population-based cohort study. Bmc Cancer. 18: 76. PMID 29334917 DOI: 10.1186/s12885-017-3971-4  0.19
2015 Gorringe KL, Hunter SM, Pang JM, Opeskin K, Hill P, Rowley SM, Choong DY, Thompson ER, Dobrovic A, Fox SB, Mann GB, Campbell IG. Copy number analysis of ductal carcinoma in situ with and without recurrence. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 28: 1174-84. PMID 26321097 DOI: 10.1038/modpathol.2015.75  0.19
2011 Davis SJ, Choong DY, Ramakrishna M, Ryland GL, Campbell IG, Gorringe KL. Analysis of the mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer. Bmc Cancer. 11: 173. PMID 21575258 DOI: 10.1186/1471-2407-11-173  0.189
2011 Askarian-Amiri ME, Crawford J, French JD, Smart CE, Smith MA, Clark MB, Ru K, Mercer TR, Thompson ER, Lakhani SR, Vargas AC, Campbell IG, Brown MA, Dinger ME, Mattick JS. SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. Rna (New York, N.Y.). 17: 878-91. PMID 21460236 DOI: 10.1261/rna.2528811  0.188
2022 DeVries AA, Dennis J, Tyrer JP, Peng PC, Coetzee SG, Reyes AL, Plummer JT, Davis BD, Chen SS, Dezem FS, Aben KKH, Anton-Culver H, Antonenkova NN, Beckmann MW, Beeghly-Fadiel A, ... ... Campbell I, et al. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. Journal of the National Cancer Institute. PMID 36210504 DOI: 10.1093/jnci/djac160  0.186
2017 Liu P, Yuan B, Carvalho CM, Wuster A, Walter K, Zhang L, Gambin T, Chong Z, Campbell IM, Coban Akdemir Z, Gelowani V, Writzl K, Bacino CA, Lindsay SJ, Withers M, et al. An Organismal CNV Mutator Phenotype Restricted to Early Human Development. Cell. 168: 830-842.e7. PMID 28235197 DOI: 10.1016/J.Cell.2017.01.037  0.186
2019 Qian F, Rookus MA, Leslie G, Risch HA, Greene MH, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, Ahmed M, Aittomäki K, Andrulis IL, Arnold N, Arun BK, Ausems MGEM, ... Campbell I, et al. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers. British Journal of Cancer. PMID 31213659 DOI: 10.1038/S41416-019-0492-8  0.185
1933 Campbell I, Maxson JH. Some Observations on the Archean Metamorphics of the Grand Canyon. Proceedings of the National Academy of Sciences of the United States of America. 19: 806-809. PMID 16577571 DOI: 10.1073/Pnas.19.9.806  0.184
2017 Tin Tin S, Elwood JM, Lawrenson R, Campbell I. Missing data on body mass index in a breast cancer register: how is it associated with patient characteristics and clinical outcomes? The New Zealand Medical Journal. 130: 21-29. PMID 28253241  0.183
2011 Anglesio MS, George J, Kulbe H, Friedlander M, Rischin D, Lemech C, Power J, Coward J, Cowin PA, House CM, Chakravarty P, Gorringe KL, Campbell IG, Okamoto A, et al. IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 2538-48. PMID 21343371 DOI: 10.1158/1078-0432.CCR-10-3314  0.183
2018 Elwood JM, Tawfiq E, TinTin S, Marshall RJ, Phung TM, Campbell I, Harvey V, Lawrenson R. Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index. Bmc Cancer. 18: 897. PMID 30223800 DOI: 10.1186/s12885-018-4791-x  0.183
2014 Charbonneau B, Moysich KB, Kalli KR, Oberg AL, Vierkant RA, Fogarty ZC, Block MS, Maurer MJ, Goergen KM, Fridley BL, Cunningham JM, Rider DN, Preston C, Hartmann LC, Lawrenson K, ... ... Campbell I, et al. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunology Research. 2: 332-40. PMID 24764580 DOI: 10.1158/2326-6066.Cir-13-0136  0.183
2013 Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, ... ... Campbell I, et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature Communications. 4: 1627. PMID 23535648 DOI: 10.1038/Ncomms2613  0.182
2009 Sun Z, Goldhirsch A, Price KN, Colleoni M, Ravaioli A, Simoncini E, Campbell I, Gelber RD, Towler M. Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancer. Breast (Edinburgh, Scotland). 18: 84-8. PMID 19243946 DOI: 10.1016/j.breast.2009.01.003  0.182
2016 Tin Tin S, Elwood JM, Lawrenson R, Campbell I, Harvey V, Seneviratne S. Differences in Breast Cancer Survival between Public and Private Care in New Zealand: Which Factors Contribute? Plos One. 11: e0153206. PMID 27054698 DOI: 10.1371/journal.pone.0153206  0.182
2015 Amankwah EK, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, ... ... Campbell IG, et al. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genetic Epidemiology. PMID 26399219 DOI: 10.1002/Gepi.21921  0.182
2016 Lawrenson R, Lao C, Elwood M, Brown C, Sarfati D, Campbell I. Urban Rural Differences in Breast Cancer in New Zealand. International Journal of Environmental Research and Public Health. 13. PMID 27727190 DOI: 10.3390/ijerph13101000  0.182
2019 Cheasley D, Wakefield MJ, Ryland GL, Allan PE, Alsop K, Amarasinghe KC, Ananda S, Anglesio MS, Au-Yeung G, Böhm M, Bowtell DDL, Brand A, Chenevix-Trench G, Christie M, Chiew YE, ... ... Campbell IG, et al. The molecular origin and taxonomy of mucinous ovarian carcinoma. Nature Communications. 10: 3935. PMID 31477716 DOI: 10.1038/S41467-019-11862-X  0.181
2014 Beumer JD, Gill G, Campbell I, Wetzig N, Ung O, Farshid G, Uren R, Stockler M, Gebski V. Sentinel node biopsy and large (≥3 cm) breast cancer. Anz Journal of Surgery. 84: 117-20. PMID 23601070 DOI: 10.1111/ans.12139  0.181
2018 Blackmore T, Lawrenson R, Lao C, Edwards M, Kuper-Hommel M, Elwood M, Campbell I. The characteristics, management and outcomes of older women with breast cancer in New Zealand. Maturitas. 112: 64-70. PMID 29704919 DOI: 10.1016/j.maturitas.2018.03.018  0.181
2023 Lawrenson R, Lao C, Stanley J, Campbell I, Krebs J, Meredith I, Koea J, Teng A, Sika-Paotonu D, Stairmand J, Gurney J. Impact of diabetes on surgery and radiotherapy for breast cancer. Breast Cancer Research and Treatment. PMID 36997750 DOI: 10.1007/s10549-023-06915-1  0.18
2003 Berchuck A, Brewer M, Rodriguez G, Campbell I. Discussion: Ovarian Cancer Prevention Gynecologic Oncology. 88. DOI: 10.1006/Gyno.2002.6687  0.179
2003 Cristiano B, Cornus N, Hannan K, Campbell I, Pearson R. 633 Specific activation of Akt3 in ovarian cancer European Journal of Cancer Supplements. 1: S190-S191. DOI: 10.1016/S1359-6349(03)90665-3  0.179
2019 Lawrenson R, Lao C, Jacobson G, Seneviratne S, Scott N, Sarfati D, Elwood M, Campbell I. Outcomes in different ethnic groups of New Zealand patients with screen-detected vs. non-screen-detected breast cancer. Journal of Medical Screening. 969141319844801. PMID 31068074 DOI: 10.1177/0969141319844801  0.178
2011 Hunter SM, Anglesio MS, Sharma R, Gilks CB, Melnyk N, Chiew YE, deFazio A, Longacre TA, Huntsman DG, Gorringe KL, Campbell IG. Copy number aberrations in benign serous ovarian tumors: a case for reclassification? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 7273-82. PMID 21976534 DOI: 10.1158/1078-0432.CCR-11-2080  0.177
2015 Hunter SM, Anglesio MS, Ryland GL, Sharma R, Chiew YE, Rowley SM, Doyle MA, Li J, Gilks CB, Moss P, Allan PE, Stephens AN, Huntsman DG, deFazio A, Bowtell DD, ... ... Campbell IG, et al. Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes. Oncotarget. PMID 26506417 DOI: 10.18632/oncotarget.5438  0.177
2016 Cuellar-Partida G, Lu Y, Dixon SC, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Doherty JA, Rossing MA, Chang-Claude J, ... Campbell I, et al. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Human Genetics. PMID 27075448 DOI: 10.1007/S00439-016-1663-9  0.177
2021 Cousens NE, Tiller J, Meiser B, Barlow-Stewart K, Rowley S, Ko YA, Mahale S, Campbell IG, Kaur R, Bankier A, Burnett L, Jacobs C, James PA, Trainer A, Neil S, et al. Evaluation of two population screening programmes for founder mutations in the Australian Jewish community: a protocol paper. Bmj Open. 11: e041186. PMID 34172541 DOI: 10.1136/bmjopen-2020-041186  0.176
2011 Lin SJ, Cawson J, Hill P, Haviv I, Jenkins M, Hopper JL, Southey MC, Campbell IG, Thompson EW. Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue. Breast Cancer Research and Treatment. 128: 505-16. PMID 21258862 DOI: 10.1007/s10549-011-1346-0  0.176
2006 Phillips WA, Russell SE, Ciavarella ML, Choong DY, Montgomery KG, Smith K, Pearson RB, Thomas RJ, Campbell IG. Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus. International Journal of Cancer. Journal International Du Cancer. 118: 2644-6. PMID 16380997 DOI: 10.1002/ijc.21706  0.175
2009 Campbell I, Polyak K, Haviv I. Clonal Mutations in the Cancer-Associated Fibroblasts: The Case against Genetic Coevolution Cancer Research. 69: 6765-6769. PMID 19706773 DOI: 10.1158/0008-5472.Can-08-4253  0.175
2015 Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N, ... ... Campbell IG, et al. Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer. Carcinogenesis. PMID 26424751 DOI: 10.1093/carcin/bgv138  0.174
2012 Takano EA, Rogers TM, Young RJ, Rayoo M, Kostos P, Ferguson R, Campbell IG, Debiec-Rychter M, Fox SB. The molecular characterisation of unusual subcutaneous spindle cell lesion of breast. Journal of Clinical Pathology. 65: 746-50. PMID 22523339 DOI: 10.1136/jclinpath-2011-200629  0.174
2017 Hendry S, Pang JB, Byrne D, Lakhani SR, Cummings MC, Campbell IG, Mann GB, Gorringe KL, Fox SB. Relationship of the breast ductal carcinoma in situ immune microenvironment with clinico-pathological and genetic features. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28611201 DOI: 10.1158/1078-0432.CCR-17-0743  0.174
2012 Johnson CE, Gorringe KL, Thompson ER, Opeskin K, Boyle SE, Wang Y, Hill P, Mann GB, Campbell IG. Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma. Breast Cancer Research and Treatment. 133: 889-98. PMID 22052326 DOI: 10.1007/s10549-011-1835-1  0.173
2021 Forbes Shepherd R, Forrest LE, Tutty E, Pearce A, Devereux L, James PA, Campbell IG, Trainer A, Young MA. Unselected Women's Experiences of Receiving Genetic Research Results for Hereditary Breast and Ovarian Cancer: A Qualitative Study. Genetic Testing and Molecular Biomarkers. 25: 741-748. PMID 34918982 DOI: 10.1089/gtmb.2021.0115  0.173
2021 Lao C, Mondal M, Kuper-Hommel M, Campbell I, Cameron MP, Lawrenson R. Breast cancer costs in New Zealand's public health system. The New Zealand Medical Journal. 134: 36-46. PMID 34788270  0.173
2010 Ramakrishna M, Williams LH, Boyle SE, Bearfoot JL, Sridhar A, Speed TP, Gorringe KL, Campbell IG. Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis. Plos One. 5: e9983. PMID 20386695 DOI: 10.1371/journal.pone.0009983  0.172
2019 Lippey J, Keogh LA, Mann GB, Campbell IG, Forrest LE. "A natural progression" - Australian women's attitudes about an individualised breast screening model. Cancer Prevention Research (Philadelphia, Pa.). PMID 31003994 DOI: 10.1158/1940-6207.CAPR-18-0443  0.172
2014 Block MS, Charbonneau B, Vierkant RA, Fogarty Z, Bamlet WR, Pharoah PD, Rossing MA, Cramer D, Pearce CL, Schildkraut J, Menon U, Kjaer SK, ... ... Campbell I, et al. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1421-7. PMID 24740199 DOI: 10.1158/1055-9965.Epi-13-0962  0.172
2010 Gorringe KL, George J, Anglesio MS, Ramakrishna M, Etemadmoghadam D, Cowin P, Sridhar A, Williams LH, Boyle SE, Yanaihara N, Okamoto A, Urashima M, Smyth GK, Campbell IG, Bowtell DD, et al. Copy number analysis identifies novel interactions between genomic loci in ovarian cancer. Plos One. 5. PMID 20844748 DOI: 10.1371/journal.pone.0011408  0.172
2011 Ramakrishna M, Williams LH, Boyle SE, Bearfoot JL, Sridhar A, Speed TP, Gorringe KL, Campbell IG. Correction: Identification of Candidate Growth Promoting Genes in Ovarian Cancer through Integrated Copy Number and Expression Analysis Plos One. 6. DOI: 10.1371/annotation/4056b510-e92d-4472-871f-2cf1f6834689  0.171
2008 Gorringe KL, Campbell IG. High-resolution copy number arrays in cancer and the problem of normal genome copy number variation. Genes, Chromosomes & Cancer. 47: 933-8. PMID 18663746 DOI: 10.1002/gcc.20595  0.171
2006 Konstantakopoulos N, Montgomery KG, Chamberlain N, Quinn MA, Baker MS, Rice GE, Georgiou HM, Campbell IG. Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells. Molecular Carcinogenesis. 45: 752-63. PMID 16705744 DOI: 10.1002/mc.20187  0.17
2018 Block MS, Vierkant RA, Rambau PF, Winham SJ, Wagner P, Traficante N, Tołoczko A, Tiezzi DG, Taran FA, Sinn P, Sieh W, Sharma R, Rothstein JH, Ramón Y Cajal T, Paz-Ares L, ... ... Campbell IG, et al. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. Mayo Clinic Proceedings. 93: 307-320. PMID 29502561 DOI: 10.1016/j.mayocp.2017.10.023  0.169
2008 Bundred NJ, Campbell ID, Davidson N, DeBoer RH, Eidtmann H, Monnier A, Neven P, von Minckwitz G, Miller JC, Schenk NL, Coleman RE. Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results. Cancer. 112: 1001-10. PMID 18205185 DOI: 10.1002/cncr.23259  0.169
1995 Foulkes WD, Stamp GW, Afzal S, Lalani N, McFarlane CP, Trowsdale J, Campbell IG. MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status. British Journal of Cancer. 72: 883-8. PMID 7547235 DOI: 10.1038/bjc.1995.428  0.169
2005 Shafren DR, Sylvester D, Johansson ES, Campbell IG, Barry RD. Oncolysis of human ovarian cancers by echovirus type 1. International Journal of Cancer. 115: 320-8. PMID 15688406 DOI: 10.1002/ijc.20866  0.168
1993 Foulkes WD, Campbell IG, Stamp GW, Trowsdale J. Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer. British Journal of Cancer. 67: 268-73. PMID 8094291 DOI: 10.1038/bjc.1993.51  0.168
2008 Smith MJ, Gill PG, Wetzig N, Sourjina T, Gebski V, Ung O, Campbell I, Kollias J, Coskinas X, Macphee A, Young L, Simes RJ, Stockler MR. Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial). Breast Cancer Research and Treatment. 117: 99-109. PMID 18925434 DOI: 10.1007/s10549-008-0202-3  0.168
2019 Olivotto IA, Link E, Phillips C, Whelan TJ, Bryant G, Kunkler IH, Westenberg AH, Purohit K, Ahern V, Graham PH, Akra M, McArdle O, Ludbrook JJ, Harvey JA, Maduro JH, ... ... Campbell ID, et al. International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 31431385 DOI: 10.1016/j.radonc.2019.07.024  0.168
2006 Cristiano BE, Chan JC, Hannan KM, Lundie NA, Marmy-Conus NJ, Campbell IG, Phillips WA, Robbie M, Hannan RD, Pearson RB. A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition. Cancer Research. 66: 11718-25. PMID 17178867 DOI: 10.1158/0008-5472.CAN-06-1968  0.166
2006 Antill YC, Mitchell G, Johnson SA, Devereux L, Milner A, Phillips KA, Campbell IG. Loss of heterozygosity analysis in ductal lavage samples from BRCA1 and BRCA2 carriers: a cautionary tale. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1396-8. PMID 16835342 DOI: 10.1158/1055-9965.EPI-05-0986  0.166
2012 Kinross KM, Montgomery KG, Kleinschmidt M, Waring P, Ivetac I, Tikoo A, Saad M, Hare L, Roh V, Mantamadiotis T, Sheppard KE, Ryland GL, Campbell IG, Gorringe KL, Christensen JG, et al. An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice. The Journal of Clinical Investigation. 122: 553-7. PMID 22214849 DOI: 10.1172/JCI59309  0.166
2004 Rae JM, Ramus SJ, Waltham M, Armes JE, Campbell IG, Clarke R, Barndt RJ, Johnson MD, Thompson EW. Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties. Clinical & Experimental Metastasis. 21: 543-52. PMID 15679052 DOI: 10.1007/s10585-004-3759-1  0.166
2009 Haviv I, Polyak K, Qiu W, Hu M, Campbell I. Origin of carcinoma associated fibroblasts. Cell Cycle (Georgetown, Tex.). 8: 589-95. PMID 19182519 DOI: 10.4161/Cc.8.4.7669  0.165
2003 Haviv I, Campbell IG. DNA microarrays for assessing ovarian cancer gene expression. Molecular and Cellular Endocrinology. 191: 121-6. PMID 12044926 DOI: 10.1016/S0303-7207(02)00063-1  0.165
2021 Dempsey K, Mathieu E, Brennan M, Snook K, Hoffman J, Campbell I, Scarlet J, Flay H, Wong AZH, Boyle F, King M, Spillane A. The role of breast reconstruction choice on body image patient-reported outcomes at four years post-mastectomy for breast cancer: A longitudinal prospective cohort study. Psycho-Oncology. PMID 34498358 DOI: 10.1002/pon.5776  0.165
2011 Amankwah EK, Wang Q, Schildkraut JM, Tsai YY, Ramus SJ, Fridley BL, Beesley J, Johnatty SE, Webb PM, Chenevix-Trench G, Dale LC, Lambrechts D, Amant F, Despierre E, ... ... Campbell I, et al. Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium. Plos One. 6: e19642. PMID 21637745 DOI: 10.1371/Journal.Pone.0019642  0.164
2015 Juraskova I, Butow P, Fisher A, Bonner C, Anderson C, Bu S, Scarlet J, Stockler MR, Wetzig N, Ung O, Campbell I. Development and piloting of a decision aid for women considering participation in the Sentinel Node Biopsy versus Axillary Clearance 2 breast cancer trial. Clinical Trials (London, England). 12: 409-17. PMID 26033878 DOI: 10.1177/1740774515586404  0.164
2012 Hunter S, Gorringe K, Anglesio M, Sharma R, Gilks B, deFazio A, Huntsman D, Campbell I. Benign serous ovarian tumour: a redefining moment? Hereditary Cancer in Clinical Practice. 10: 1-1. DOI: 10.1186/1897-4287-10-S2-A83  0.164
2020 Subramanian DN, Zethoven M, McInerny S, Morgan JA, Rowley SM, Lee JEA, Li N, Gorringe KL, James PA, Campbell IG. Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes. Nature Communications. 11: 1640. PMID 32242007 DOI: 10.1038/s41467-020-15461-z  0.164
2018 Elder K, Kader T, Hill P, Opeskin K, Goode D, Pang J, Fox S, Mann G, Campbell I, Gorringe K. Abstract P3-04-08: Genomic analysis of breast papillomas Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P3-04-08  0.163
2012 Ryland GL, Bearfoot JL, Doyle MA, Boyle SE, Choong DYH, Rowley SM, Tothill RW, Gorringe KL, Campbell IG. MicroRNA genes and their target 3′-untranslated regions are infrequently somatically mutated in ovarian cancers Plos One. 7. PMID 22536442 DOI: 10.1371/journal.pone.0035805  0.162
2015 Pang JM, Gorringe KL, Wong SQ, Dobrovic A, Campbell IG, Fox SB. Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast. Breast Cancer Research : Bcr. 17: 80. PMID 26078038 DOI: 10.1186/s13058-015-0586-z  0.161
2003 Thomas NA, Neville PJ, Baxter SW, Campbell IG. Genetic analysis of benign ovarian tumors. International Journal of Cancer. 105: 499-505. PMID 12712441 DOI: 10.1002/ijc.11107  0.161
2003 Patrikis MI, Bryan EJ, Thomas NA, Rice GE, Quinn MA, Baker MS, Campbell IG. Mutation analysis of CDP, TP53, and KRAS in uterine leiomyomas Molecular Carcinogenesis. 37: 61-64. PMID 12766905 DOI: 10.1002/mc.10127  0.161
2015 Hunter SM, Rowley SM, Clouston D, Li J, Lupat R, Krishnananthan N, Risbridger G, Taylor R, Bolton D, Campbell IG, Thorne H. Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer. Urologic Oncology. PMID 26585945 DOI: 10.1016/j.urolonc.2015.10.009  0.161
2010 Handolias DD, Chan P, Phillips W, Fox SB, Pearson R, Sawyer S, Campbell I, Salemi R, McArthur GA. Activation of the PI3K pathway and prognostic information in epithelial ovarian cancer. Journal of Clinical Oncology. 28: 10610-10610. DOI: 10.1200/Jco.2010.28.15_Suppl.10610  0.16
2019 Patel VL, Busch EL, Friebel TM, Cronin A, Leslie G, McGuffog L, Adlard J, Agata S, Agnarsson BA, Ahmed M, Aittomäki K, Alducci E, Andrulis IL, Arason A, Arnold N, ... ... Campbell IG, et al. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness. Cancer Research. PMID 31723001 DOI: 10.1158/0008-5472.Can-19-1840  0.16
2015 Gambin T, Jhangiani SN, Below JE, Campbell IM, Wiszniewski W, Muzny DM, Staples J, Morrison AC, Bainbridge MN, Penney S, McGuire AL, Gibbs RA, Lupski JR, Boerwinkle E. Secondary findings and carrier test frequencies in a large multiethnic sample. Genome Medicine. 7: 54. PMID 26195989 DOI: 10.1186/S13073-015-0171-1  0.159
2022 Cheasley D, Fernandez ML, Köbel M, Kim H, Dawson A, Hoenisch J, Bittner M, Chiu DS, Talhouk A, Gilks CB, Jayawardana MW, Pishas KI, Mes-Masson AM, Provencher D, Nigam A, ... ... Campbell IG, et al. Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression. Npj Precision Oncology. 6: 47. PMID 35768582 DOI: 10.1038/s41698-022-00288-2  0.158
2013 Hunter SM, Gorringe KL, Anglesio MS, Sharma R, Chiew Y, Moss P, Stephens A, Gilks CB, Hunstman D, deFazio A, Campbell I. Abstract A13: Molecular profiling of low grade serous ovarian tumors Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A13  0.158
2002 Hamill J, Campbell ID, Mayall F, Bartlett AS, Darlington A. Improved breast cytology results with near patient FNA diagnosis. Acta Cytologica. 46: 19-24. PMID 11845809  0.158
2013 Ryland GL, Hunter SM, Doyle MA, Rowley SM, Christie M, Allan PE, Bowtell DD, Gorringe KL, Campbell IG. RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary. The Journal of Pathology. 229: 469-76. PMID 23096461 DOI: 10.1002/path.4134  0.157
2022 Forrest LE, Forbes Shepherd R, Tutty E, Pearce A, Campbell I, Devereux L, Trainer AH, James PA, Young MA. The Clinical and Psychosocial Outcomes for Women Who Received Unexpected Clinically Actionable Germline Information Identified through Research: An Exploratory Sequential Mixed-Methods Comparative Study. Journal of Personalized Medicine. 12. PMID 35887609 DOI: 10.3390/jpm12071112  0.157
2013 Harrison SM, Campbell IM, Keays M, Granberg CF, Villanueva C, Tannin G, Zinn AR, Castrillon DH, Shaw CA, Stankiewicz P, Baker LA. Screening and familial characterization of copy-number variations in NR5A1 in 46,XY disorders of sex development and premature ovarian failure. American Journal of Medical Genetics. Part A. 161: 2487-94. PMID 23918653 DOI: 10.1002/Ajmg.A.36084  0.157
2018 Yang Y, Wu L, Shu X, Lu Y, Shu XO, Cai Q, Beeghly-Fadiel A, Li B, Ye F, Berchuck A, Anton-Culver H, Banerjee S, Benitez J, Bjørge L, Brenton JD, ... ... Campbell IG, et al. Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk. Cancer Research. PMID 30559148 DOI: 10.1158/0008-5472.Can-18-2726  0.156
2009 Gorringe KL, Ramakrishna M, Williams LH, Sridhar A, Boyle SE, Bearfoot JL, Li J, Anglesio MS, Campbell IG. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis. Genes, Chromosomes & Cancer. 48: 931-42. PMID 19603523 DOI: 10.1002/gcc.20694  0.156
2023 Lippey J, Keogh L, Campbell I, Mann GB, Forrest LE. Impact of a risk based breast screening decision aid on understanding, acceptance and decision making. Npj Breast Cancer. 9: 65. PMID 37553371 DOI: 10.1038/s41523-023-00569-4  0.156
2024 Blackmore T, Norman K, Burrett V, Scarlet J, Campbell I, Lawrenson R. The factors involved in surgical decision-making in younger women diagnosed with breast cancer in Aotearoa New Zealand: A qualitative analysis. Journal of Health Psychology. 13591053241237075. PMID 38456356 DOI: 10.1177/13591053241237075  0.156
2017 Phelan CM, Kuchenbaecker KB, Tyrer JP, Kar SP, Lawrenson K, Winham SJ, Dennis J, Pirie A, Riggan MJ, Chornokur G, Earp MA, Lyra PC, Lee JM, Coetzee S, Beesley J, ... ... Campbell I, et al. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nature Genetics. PMID 28346442 DOI: 10.1038/ng.3826  0.156
2014 Boone PM, Yuan B, Campbell IM, Scull JC, Withers MA, Baggett BC, Beck CR, Shaw CJ, Stankiewicz P, Moretti P, Goodwin WE, Hein N, Fink JK, Seong MW, Seo SH, et al. The Alu-rich genomic architecture of SPAST predisposes to diverse and functionally distinct disease-associated CNV alleles. American Journal of Human Genetics. 95: 143-61. PMID 25065914 DOI: 10.1016/J.Ajhg.2014.06.014  0.156
2016 Ong JS, Cuellar-Partida G, Lu Y, Ovarian Cancer Study A, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Anne Doherty J, Anne Rossing M, Chang-Claude J, ... Campbell I, et al. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology. PMID 27594614 DOI: 10.1093/Ije/Dyw207  0.156
2020 Lippey J, Keogh L, Mann G, Campbell I, Forrest L. OP3 Are Victorian women interested in risk stratified breast screening? The Breast. 50: 153-154. DOI: 10.1016/j.breast.2020.01.011  0.155
2014 Emmanuel C, Chiew YE, George J, Etemadmoghadam D, Anglesio MS, Sharma R, Russell P, Kennedy C, Fereday S, Hung J, Galletta L, Hogg R, Wain GV, Brand A, Balleine R, ... ... Campbell I, et al. Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6618-30. PMID 25316818 DOI: 10.1158/1078-0432.Ccr-14-1292  0.153
2000 Thomas EJ, Campbell IG. Molecular genetic defects in endometriosis Gynecologic and Obstetric Investigation. 50: 44-50. PMID 11093061 DOI: 10.1159/000052878  0.153
2020 Kang EY, Cheasley D, LePage C, Wakefield MJ, da Cunha Torres M, Rowley S, Salazar C, Xing Z, Allan P, Bowtell DDL, Mes-Masson AM, Provencher DM, Rahimi K, Kelemen LE, Fasching PA, ... Campbell I, et al. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 32724153 DOI: 10.1038/S41379-020-0618-9  0.153
2018 Alexiadis M, Rowley SM, Chu S, Leung DTH, Stewart CJR, Amarasinghe KC, Campbell IG, Fuller PJ. Mutational Landscape of Ovarian Adult Granulosa Cell Tumors from Whole Exome and Targeted TERT Promoter Sequencing. Molecular Cancer Research : McR. PMID 30166312 DOI: 10.1158/1541-7786.MCR-18-0359  0.153
2023 Saner FAM, Takahashi K, Budden T, Pandey A, Ariyaratne D, Zwimpfer TA, Meagher NS, Fereday S, Twomey L, Pishas KI, Hoang T, Bolithon A, Traficante N, Alsop K, Christie EL, ... ... Campbell I, et al. Concurrent RB1 loss and -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma. Medrxiv : the Preprint Server For Health Sciences. PMID 37986741 DOI: 10.1101/2023.11.09.23298321  0.152
2004 Montgomery KG, Liu MC, Eccles DM, Campbell IG. The DNMT3B C-->T promoter polymorphism and risk of breast cancer in a British population: a case-control study. Breast Cancer Research : Bcr. 6: R390-4. PMID 15217506 DOI: 10.1186/bcr807  0.152
2021 Heinze K, Nazeran TM, Lee S, Krämer P, Cairns ES, Chiu DS, Leung SCY, Kang EY, Meagher NS, Kennedy CJ, Boros J, Kommoss F, Vollert HW, Heitze F, du Bois A, ... ... Campbell I, et al. Validated biomarker assays confirm ARID1A loss is confounded with MMR deficiency, CD8 TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas. The Journal of Pathology. PMID 34897700 DOI: 10.1002/path.5849  0.152
2015 Ryland GL, Hunter SM, Doyle MA, Caramia F, Li J, Rowley SM, Christie M, Allan PE, Stephens AN, Bowtell DD, Campbell IG, Gorringe KL. Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors. Genome Medicine. 7: 87. PMID 26257827 DOI: 10.1186/s13073-015-0210-y  0.152
2005 Brunton M, Jordan C, Campbell I. Anxiety before, during, and after participation in a population-based screening mammography programme in Waikato Province, New Zealand. The New Zealand Medical Journal. 118: U1299. PMID 15711632  0.151
2019 Grant DJ, Manichaikul A, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Moorman PG, Peres LC, Peters ES, Schwartz AG, Terry PD, Wang XQ, Keku TO, ... Campbell I, et al. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women. Cancer Medicine. PMID 31001917 DOI: 10.1002/Cam4.1996  0.151
1997 Roy WJ, Watson RH, Hitchcock A, Campbell IG. Frequent loss of heterozygosity on chromosomes 7 and 9 in benign epithelial ovarian tumours. Oncogene. 15: 2031-5. PMID 9366520 DOI: 10.1038/sj.onc.1201372  0.149
2014 Hunter SM, Ryland GL, Moss P, Gorringe KL, Campbell IG. Genomic aberrations of BRCA1-mutated fallopian tube carcinomas. The American Journal of Pathology. 184: 1871-6. PMID 24726640 DOI: 10.1016/j.ajpath.2014.02.013  0.149
2004 Thompson EW, Waltham M, Ramus SJ, Hutchins AM, Armes JE, Campbell IG, Williams ED, Thompson PR, Rae JM, Johnson MD, Clarke R. LCC15-MB cells are MDA-MB-435: a review of misidentified breast and prostate cell lines. Clinical & Experimental Metastasis. 21: 535-41. PMID 15679051 DOI: 10.1007/s10585-004-4117-z  0.149
2022 Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, Agata S, Andrulis IL, Anton-Culver H, Antonenkova NN, Aravantinos G, Arun BK, Augustinsson A, Balmaña J, ... ... Campbell I, et al. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics : Ejhg. PMID 35314806 DOI: 10.1038/s41431-022-01085-y  0.149
2019 Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, ... Campbell I, et al. Publisher Correction: Shared heritability and functional enrichment across six solid cancers. Nature Communications. 10: 4386. PMID 31548585 DOI: 10.1038/S41467-019-12095-8  0.148
2016 Permuth JB, Reid B, Earp M, Chen YA, Monteiro AN, Chen Z, Aocs Study Group, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vanderstichele A, Van Niewenhuyse E, Vergote I, Rossing MA, ... Campbell I, et al. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget. 7: 72381-72394. PMID 27911851 DOI: 10.18632/Oncotarget.10546  0.147
2012 Campbell ID. A shining light in the New Zealand cancer gloom New Zealand Medical Journal. 125: 9-10. PMID 22932650  0.146
2001 Neville PJ, Thomas N, Campbell IG. Loss of heterozygosity at 7q22 and mutation analysis of the CDP gene in human epithelial ovarian tumors. International Journal of Cancer. 91: 345-9. PMID 11169958 DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1050>3.0.CO;2-1  0.145
2015 Campbell IM, Shaw CA, Stankiewicz P, Lupski JR. Somatic mosaicism: implications for disease and transmission genetics. Trends in Genetics : Tig. 31: 382-92. PMID 25910407 DOI: 10.1016/J.Tig.2015.03.013  0.144
2013 Boone PM, Campbell IM, Baggett BC, Soens ZT, Rao MM, Hixson PM, Patel A, Bi W, Cheung SW, Lalani SR, Beaudet AL, Stankiewicz P, Shaw CA, Lupski JR. Deletions of recessive disease genes: CNV contribution to carrier states and disease-causing alleles. Genome Research. 23: 1383-94. PMID 23685542 DOI: 10.1101/Gr.156075.113  0.144
2020 Gorringe KL, Cheasley D, Wakefield MJ, Ryland GL, Allan PE, Alsop K, Amarasinghe KC, Ananda S, Bowtell DDL, Christie M, Chiew YE, Churchman M, DeFazio A, Fereday S, Gilks CB, ... ... Campbell IG, et al. Therapeutic options for mucinous ovarian carcinoma. Gynecologic Oncology. PMID 31902686 DOI: 10.1016/J.Ygyno.2019.12.015  0.144
2022 Lippey J, Keogh L, Campbell I, Mann GB, Forrest L. Development and pilot testing of an online decision aid for women considering risk-stratified breast screening. Journal of Community Genetics. 13: 137-141. PMID 35060087 DOI: 10.1007/s12687-021-00571-y  0.141
2018 Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, Olah E, Olopade OI, Solano AR, Teo SH, Thomassen M, Weitzel JN, Chan TL, Couch FJ, Goldgar DE, ... Campbell I, et al. Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations. Human Mutation. PMID 29446198 DOI: 10.1002/Humu.23406  0.141
2022 Hardcastle A, Berry AM, Campbell IM, Zhao X, Liu P, Gerard AE, Rosenfeld JA, Sisoudiya SD, Hernandez-Garcia A, Loddo S, Di Tommaso S, Novelli A, Dentici ML, Capolino R, Digilio MC, et al. Identifying phenotypic expansions for congenital diaphragmatic hernia plus (CDH+) using DECIPHER data. American Journal of Medical Genetics. Part A. PMID 35904974 DOI: 10.1002/ajmg.a.62919  0.141
2018 Natanzon Y, Köbel M, Winham SJ, Armasu SM, McCauley BM, Vierkant RA, Cunningham JM, Bowtell D, Campbell IG, Chang-Claude J, deFazio A, Fasching PA, Goodman MT, Karlan BY, Modugno F, et al. Abstract 225: Tumor-infiltrating CD8-positive T-lymphocytes in tubo-ovarian high-grade serous cancer are associated with multiple germline variants in 22q12.1 in a genome-wide association analysis Cancer Research. 78: 225-225. DOI: 10.1158/1538-7445.Am2018-225  0.141
2016 Ballinger ML, Goode DL, Ray-Coquard I, James PA, Mitchell G, Niedermayr E, Puri A, Schiffman JD, Dite GS, Cipponi A, Maki RG, Brohl AS, Myklebost O, Stratford EW, Lorenz S, ... ... Campbell IG, et al. Monogenic and polygenic determinants of sarcoma risk: an international genetic study. The Lancet. Oncology. PMID 27498913 DOI: 10.1016/S1470-2045(16)30147-4  0.14
2015 Lung MS, Trainer AH, Campbell I, Lipton L. Familial colorectal cancer. Internal Medicine Journal. 45: 482-91. PMID 25955461 DOI: 10.1111/Imj.12736  0.14
2008 Gorringe KL, Campbell IG. A rational approach to cancer therapy. Genome Biology. 9: 306. PMID 18466646 DOI: 10.1186/gb-2008-9-5-306  0.139
2015 Karaca E, Harel T, Pehlivan D, Jhangiani SN, Gambin T, Coban Akdemir Z, Gonzaga-Jauregui C, Erdin S, Bayram Y, Campbell IM, Hunter JV, Atik MM, Van Esch H, Yuan B, Wiszniewski W, et al. Genes that Affect Brain Structure and Function Identified by Rare Variant Analyses of Mendelian Neurologic Disease. Neuron. 88: 499-513. PMID 26539891 DOI: 10.1016/J.Neuron.2015.09.048  0.138
2022 Meagher NS, Gorringe KL, Wakefield MJ, Bolithon A, Pang CNI, Chiu DS, Anglesio MS, Mallitt KA, Doherty JA, Harris HR, Schildkraut JM, Berchuck A, Cushing-Haugen KL, Chezar K, Chou A, ... ... Campbell I, et al. Gene expression profiling of mucinous ovarian tumors and comparison with upper and lower gastrointestinal tumors identifies markers associated with adverse outcomes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 36222710 DOI: 10.1158/1078-0432.CCR-22-1206  0.136
1994 Englefield P, Foulkes WD, Campbell IG. Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12. British Journal of Cancer. 70: 905-7. PMID 7947096 DOI: 10.1038/bjc.1994.418  0.135
2009 Cheuk W, Chan AC, Lam WL, Chow SM, Crowley P, Lloydd R, Campbell I, Thorburn M, Chan JK. IgG4-related sclerosing mastitis: description of a new member of the IgG4-related sclerosing diseases. The American Journal of Surgical Pathology. 33: 1058-64. PMID 19384187 DOI: 10.1097/PAS.0b013e3181998cbe  0.135
2023 Pendleton KE, Hernandez-Garcia A, Lyu JM, Campbell IM, Shaw CA, Vogt J, High FA, Donahoe PK, Chung WK, Scott DA. Haploinsufficiency Contributes to the Development of Congenital Diaphragmatic Hernia. Journal of Pediatric Genetics. 13: 29-34. PMID 38567173 DOI: 10.1055/s-0043-1767731  0.135
1996 Tavassoli M, Steingrimsdottir H, Pierce E, Jiang X, Alagoz M, Farzaneh F, Campbell IG. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21 British Journal of Cancer. 74: 115-119. PMID 8679443 DOI: 10.1038/bjc.1996.324  0.134
2022 Chua BH, Link EK, Kunkler IH, Whelan TJ, Westenberg AH, Gruber G, Bryant G, Ahern V, Purohit K, Graham PH, Akra M, McArdle O, O'Brien P, Harvey JA, Kirkove C, ... ... Campbell ID, et al. Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study. Lancet (London, England). 400: 431-440. PMID 35934006 DOI: 10.1016/S0140-6736(22)01246-6  0.134
2023 Köbel M, Kang EY, Weir A, Rambau PF, Lee CH, Nelson GS, Ghatage P, Meagher NS, Riggan MJ, Alsop J, Anglesio MS, Beckmann MW, Bisinotto C, Boisen M, Boros J, ... ... Campbell I, et al. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. The Journal of Pathology. Clinical Research. PMID 36948887 DOI: 10.1002/cjp2.311  0.133
2015 Risbridger G, Sliwinski A, Thorne H, Taylor R, Papargiris M, Hunter S, Campbell I, Thorne H, Li J, Mitchell G, Clouston D, Bristow R, Murphy D, Frydenberg M, Bolton D. 2569 Identifying high risk features and genomic instability in men with familial prostate cancer European Journal of Cancer. 51: S500-S501. DOI: 10.1016/S0959-8049(16)31388-0  0.133
2022 Glewis S, Alexander M, Lingaratnam S, Lee B, Campbell I, Krishnasamy M, IJzerman M, Fagery M, Harris S, Georgiou C, Underhill C, Warren M, Campbell R, Martin J, Tie J, et al. Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial. Acta Oncologica (Stockholm, Sweden). 1-4. PMID 35972781 DOI: 10.1080/0284186X.2022.2109423  0.13
2018 Salazar C, Campbell IG, Gorringe KL. When Is "Type I" Ovarian Cancer Not "Type I"? Indications of an Out-Dated Dichotomy. Frontiers in Oncology. 8: 654. PMID 30627526 DOI: 10.3389/fonc.2018.00654  0.13
2015 Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... Campbell I, et al. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 48: 101. PMID 26711112 DOI: 10.1038/Ng0116-101B  0.13
2018 Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, Hein A, Lambrechts D, Lambrechts S, Van Nieuwenhuysen E, Vergote I, Rossing MA, Doherty JA, ... ... Campbell IG, et al. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences. 19. PMID 30134598 DOI: 10.3390/Ijms19092473  0.13
2012 Hunter SM, Gorringe KL, Christie M, Rowley SM, Bowtell DD, Campbell IG. Pre-invasive ovarian mucinous tumors are characterized by CDKN2A and RAS pathway aberrations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5267-77. PMID 22891197 DOI: 10.1158/1078-0432.CCR-12-1103  0.13
2017 Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, Toloczko A, Hein A, Bouligny AL, Jensen A, Osorio A, Hartkopf AD, Ryan A, ... ... Campbell IG, et al. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. Jama Oncology. e173290. PMID 29049607 DOI: 10.1001/Jamaoncol.2017.3290  0.129
2014 Campbell IM, Stewart JR, James RA, Lupski JR, Stankiewicz P, Olofsson P, Shaw CA. Parent of origin, mosaicism, and recurrence risk: probabilistic modeling explains the broken symmetry of transmission genetics. American Journal of Human Genetics. 95: 345-59. PMID 25242496 DOI: 10.1016/J.Ajhg.2014.08.010  0.129
2014 Campbell IM, Yuan B, Robberecht C, Pfundt R, Szafranski P, McEntagart ME, Nagamani SC, Erez A, Bartnik M, WiÅ›niowiecka-Kowalnik B, Plunkett KS, Pursley AN, Kang SH, Bi W, Lalani SR, et al. Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders. American Journal of Human Genetics. 95: 173-82. PMID 25087610 DOI: 10.1016/J.Ajhg.2014.07.003  0.129
2018 Song X, Beck CR, Du R, Campbell IM, Coban-Akdemir Z, Gu S, Breman AM, Stankiewicz P, Ira G, Shaw CA, Lupski JR. Predicting human genes susceptible to genomic instability associated with Alu/Alu-mediated rearrangements. Genome Research. PMID 29907612 DOI: 10.1101/Gr.229401.117  0.129
2013 Gonzaga-Jauregui C, Lotze T, Jamal L, Penney S, Campbell IM, Pehlivan D, Hunter JV, Woodbury SL, Raymond G, Adesina AM, Jhangiani SN, Reid JG, Muzny DM, Boerwinkle E, Lupski JR, et al. Mutations in VRK1 associated with complex motor and sensory axonal neuropathy plus microcephaly. Jama Neurology. 70: 1491-8. PMID 24126608 DOI: 10.1001/Jamaneurol.2013.4598  0.128
2016 James RA, Campbell IM, Chen ES, Boone PM, Rao MA, Bainbridge MN, Lupski JR, Yang Y, Eng CM, Posey JE, Shaw CA. A visual and curatorial approach to clinical variant prioritization and disease gene discovery in genome-wide diagnostics. Genome Medicine. 8: 13. PMID 26838676 DOI: 10.1186/S13073-016-0261-8  0.128
2013 Chong C, Walters D, de Silva P, Taylor C, Spillane A, Kollias J, Pyke C, Campbell I, Maddern G. Initial axillary surgery: results from the BreastSurgANZ Quality Audit. Anz Journal of Surgery. PMID 24251959 DOI: 10.1111/ans.12455  0.128
1994 Foulkes WD, Englefield P, Campbell IG. Mutation analysis of RASK and the 'FLR exon' of NF1 in sporadic ovarian carcinoma. European Journal of Cancer (Oxford, England : 1990). 528-30. PMID 8018414 DOI: 10.1016/0959-8049(94)90432-4  0.126
2013 Campbell IM, Rao M, Arredondo SD, Lalani SR, Xia Z, Kang SH, Bi W, Breman AM, Smith JL, Bacino CA, Beaudet AL, Patel A, Cheung SW, Lupski JR, Stankiewicz P, et al. Fusion of large-scale genomic knowledge and frequency data computationally prioritizes variants in epilepsy. Plos Genetics. 9: e1003797. PMID 24086149 DOI: 10.1371/Journal.Pgen.1003797  0.125
2011 Campbell IM, Kolodziejska KE, Quach MM, Wolf VL, Cheung SW, Lalani SR, Ramocki MB, Stankiewicz P. TGFBR2 deletion in a 20-month-old female with developmental delay and microcephaly. American Journal of Medical Genetics. Part A. 155: 1442-7. PMID 21567932 DOI: 10.1002/ajmg.a.34015  0.124
2016 Lobachevsky P, Leong T, Daly P, Smith J, Best N, Thompson ER, Li N, Campbell IG, Martin RF, Martin OA. Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity. Cancer Letters. PMID 27693457 DOI: 10.1016/j.canlet.2016.09.010  0.123
2014 Li J, Doyle MA, Saeed I, Wong SQ, Mar V, Goode DL, Caramia F, Doig K, Ryland GL, Thompson ER, Hunter SM, Halgamuge SK, Ellul J, Dobrovic A, Campbell IG, et al. Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: a virtual appliance approach for instant deployment. Plos One. 9: e95217. PMID 24752294 DOI: 10.1371/journal.pone.0095217  0.121
2013 Boone PM, Soens ZT, Campbell IM, Stankiewicz P, Cheung SW, Patel A, Beaudet AL, Plon SE, Shaw CA, McGuire AL, Lupski JR. Incidental copy-number variants identified by routine genome testing in a clinical population. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 15: 45-54. PMID 22878507 DOI: 10.1038/Gim.2012.95  0.12
2024 Boyle L, Lawrenson R, Nosa V, Campbell I, Tin Tin S. Ethnic inequities in use of breast conserving surgery and radiation therapy in Aotearoa/New Zealand: which factors contribute? Breast Cancer Research and Treatment. PMID 38536575 DOI: 10.1007/s10549-024-07289-8  0.12
2024 Meester JAN, Hebert A, Bastiaansen M, Rabaut L, Bastianen J, Boeckx N, Ashcroft K, Atwal PS, Benichou A, Billon C, Blankensteijn JD, Brennan P, Bucks SA, Campbell IM, Conrad S, et al. Expanding the clinical spectrum of biglycan-related Meester-Loeys syndrome. Npj Genomic Medicine. 9: 22. PMID 38531898 DOI: 10.1038/s41525-024-00413-z  0.12
2015 Yuan B, Liu P, Gupta A, Beck CR, Tejomurtula A, Campbell IM, Gambin T, Simmons AD, Withers MA, Harris RA, Rogers J, Schwartz DC, Lupski JR. Comparative Genomic Analyses of the Human NPHP1 Locus Reveal Complex Genomic Architecture and Its Regional Evolution in Primates. Plos Genetics. 11: e1005686. PMID 26641089 DOI: 10.1371/Journal.Pgen.1005686  0.119
2015 Kelemen LE, Lawrenson K, Tyrer J, Li Q, Lee JM, Seo JH, Phelan CM, Beesley J, Chen X, Spindler TJ, Aben KKH, Anton-Culver H, Antonenkova N, Baker H, Bandera EV, ... ... Campbell IG, et al. Genome-wide significant risk associations for mucinous ovarian carcinoma Nature Genetics. 47: 888-897. DOI: 10.1038/ng.3336  0.119
2022 Tiller JM, Cousens NE, Kaur R, Rowley S, Ko YA, Mahale S, Bankier A, Meiser B, Barlow-Stewart K, Burnett L, Jacobs C, James P, Trainer A, Neil S, Campbell IG, et al. Population-based testing programmes are highly acceptable in the Jewish community: results of the JeneScreen Study. Journal of Medical Genetics. PMID 36763037 DOI: 10.1136/jmedgenet-2022-108519  0.118
2013 Wiszniewski W, Hunter JV, Hanchard NA, Willer JR, Shaw C, Tian Q, Illner A, Wang X, Cheung SW, Patel A, Campbell IM, Gelowani V, Hixson P, Ester AR, Azamian MS, et al. TM4SF20 ancestral deletion and susceptibility to a pediatric disorder of early language delay and cerebral white matter hyperintensities. American Journal of Human Genetics. 93: 197-210. PMID 23810381 DOI: 10.1016/J.Ajhg.2013.05.027  0.117
2013 Shuvarikov A, Campbell IM, Dittwald P, Neill NJ, Bialer MG, Moore C, Wheeler PG, Wallace SE, Hannibal MC, Murray MF, Giovanni MA, Terespolsky D, Sodhi S, Cassina M, Viskochil D, et al. Recurrent HERV-H-mediated 3q13.2-q13.31 deletions cause a syndrome of hypotonia and motor, language, and cognitive delays. Human Mutation. 34: 1415-23. PMID 23878096 DOI: 10.1002/humu.22384  0.117
2021 Pishas KI, Cowley KJ, Pandey A, Hoang T, Beach JA, Luu J, Vary R, Smith LK, Shembrey CE, Rashoo N, White MO, Simpson KJ, Bild A, Griffiths JI, Cheasley D, ... Campbell I, et al. Phenotypic Consequences of Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer. Cancers. 13. PMID 34830797 DOI: 10.3390/cancers13225644  0.117
2009 Polyak K, Haviv I, Campbell IG. Co-evolution of tumor cells and their microenvironment. Trends in Genetics : Tig. 25: 30-8. PMID 19054589 DOI: 10.1016/j.tig.2008.10.012  0.116
2023 Campbell I, Wetzig N, Ung O, Espinoza D, Farshid G, Collins J, Kollias J, Gebski V, Mister R, Simes RJ, Stockler MR, Gill G. 10-Year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection. Breast (Edinburgh, Scotland). 70: 70-75. PMID 37393644 DOI: 10.1016/j.breast.2023.06.009  0.115
2021 Sheppard SE, Campbell IM, Harr MH, Gold N, Li D, Bjornsson HT, Cohen JS, Fahrner JA, Fatemi A, Harris JR, Nowak C, Stevens CA, Grand K, Au M, Graham JM, et al. Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann-Steiner syndrome. American Journal of Medical Genetics. Part A. PMID 33783954 DOI: 10.1002/ajmg.a.62124  0.115
2020 Lung MS, Mitchell CA, Doyle MA, Lynch AC, Gorringe KL, Bowtell DDL, Campbell IG, Trainer AH. Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei. Bmc Cancer. 20: 369. PMID 32357859 DOI: 10.1186/s12885-020-6705-y  0.115
1998 Watson RH, Neville PJ, Roy WJ, Hitchcock A, Campbell IG. Loss of heterozygosity on chromosomes 7p, 7q, 9p and 11q is an early event in ovarian tumorigenesis. Oncogene. 17: 207-12. PMID 9674705 DOI: 10.1038/sj.onc.1201945  0.114
1997 Watson RH, Roy WJ, Davis M, Hitchcock A, Campbell IG. Loss of heterozygosity at the alpha-inhibin locus on chromosome 2q is not a feature of human granulosa cell tumors. Gynecologic Oncology. 65: 387-90. PMID 9190962 DOI: 10.1006/gyno.1997.4682  0.114
2015 Shaw CA, Campbell IM. Variant interpretation through Bayesian fusion of frequency and genomic knowledge. Genome Medicine. 7: 4. PMID 25632303 DOI: 10.1186/S13073-015-0129-3  0.113
2003 Gloyn AL, Noordam K, Willemsen MA, Ellard S, Lam WW, Campbell IW, Midgley P, Shiota C, Buettger C, Magnuson MA, Matschinsky FM, Hattersley AT. Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations. Diabetes. 52: 2433-40. PMID 12941786 DOI: 10.2337/Diabetes.52.9.2433  0.113
2015 Gu S, Yuan B, Campbell IM, Beck CR, Carvalho CM, Nagamani SC, Erez A, Patel A, Bacino CA, Shaw CA, Stankiewicz P, Cheung SW, Bi W, Lupski JR. Alu-mediated diverse and complex pathogenic copy-number variants within human chromosome 17 at p13.3. Human Molecular Genetics. 24: 4061-77. PMID 25908615 DOI: 10.1093/Hmg/Ddv146  0.112
2014 Karaca E, Weitzer S, Pehlivan D, Shiraishi H, Gogakos T, Hanada T, Jhangiani SN, Wiszniewski W, Withers M, Campbell IM, Erdin S, Isikay S, Franco LM, Gonzaga-Jauregui C, Gambin T, et al. Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function. Cell. 157: 636-50. PMID 24766809 DOI: 10.1016/J.Cell.2014.02.058  0.112
2020 Kommoss FK, Cheasley D, Wakefield MJ, Scott CL, Campbell IG, Gorringe K, Gilks CB. Primary mucinous ovarian neoplasms rarely exhibit a germ cell histogenesis. Histopathology. PMID 33151585 DOI: 10.1111/his.14297  0.112
2014 Kelemen LE, Terry KL, Goodman MT, Webb PM, Bandera EV, McGuire V, Rossing MA, Wang Q, Dicks E, Tyrer JP, Song H, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Timorek A, ... ... Campbell IG, et al. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Molecular Nutrition & Food Research. 58: 2023-35. PMID 25066213 DOI: 10.1002/Mnfr.201400068  0.11
2020 Hunter SM, Dall GV, Doyle MA, Lupat R, Li J, Allan P, Rowley SM, Bowtell D, Campbell IG, Gorringe KL. Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours. Bmc Research Notes. 13: 349. PMID 32698852 DOI: 10.1186/s13104-020-05194-z  0.109
2017 Ryland GL, Hunter SM, Doyle MA, Caramia F, Li J, Rowley SM, Christie M, Allan PE, Stephens AN, Bowtell DD, Campbell IG, Gorringe KL. Erratum to: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors. Genome Medicine. 9: 1. PMID 28081715 DOI: 10.1186/s13073-016-0392-y  0.109
2015 Campbell I, Cavanagh S, Creighton J, French R, Banerjee S, Kerr E, Shirley R. To infiltrate or not? Acute effects of local anaesthetic in breast surgery. Anz Journal of Surgery. 85: 353-7. PMID 24754798 DOI: 10.1111/ans.12541  0.108
2019 Meagher NS, Wang L, Rambau PF, Intermaggio MP, Huntsman DG, Wilkens LR, El-Bahrawy MA, Ness RB, Odunsi K, Steed H, Herpel E, Anglesio MS, Zhang B, Lambie N, Swerdlow AJ, ... ... Campbell I, et al. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 31239549 DOI: 10.1038/S41379-019-0302-0  0.107
1997 Campbell IG, Schroff R, Englefield P, Eccles DM. BRCA1 polymorphisms [2] British Journal of Cancer. 75: 1854-1855. PMID 9192995 DOI: 10.1038/bjc.1997.318  0.105
2005 Thompson ER, Herbert SC, Forrest SM, Campbell IG. Whole genome SNP arrays using DNA derived from formalin-fixed, paraffin-embedded ovarian tumor tissue. Human Mutation. 26: 384-9. PMID 16116623 DOI: 10.1002/humu.20220  0.105
2022 Campbell IM, Crowley TB, Keena B, Donoghue S, McManus ML, Zackai EH. The experience of one pediatric geneticist with telemedicine-based clinical diagnosis. American Journal of Medical Genetics. Part A. PMID 35906847 DOI: 10.1002/ajmg.a.62920  0.104
2021 Scott TM, Campbell IM, Hernandez-Garcia A, Lalani SR, Liu P, Shaw CA, Rosenfeld JA, Scott DA. Clinical exome sequencing data reveal high diagnostic yields for congenital diaphragmatic hernia plus (CDH+) and new phenotypic expansions involving CDH. Journal of Medical Genetics. PMID 33461977 DOI: 10.1136/jmedgenet-2020-107317  0.104
1992 Ragoussis J, Senger G, Trowsdale J, Campbell IG. Genomic organization of the human folate receptor genes on chromosome 11q13. Genomics. 14: 423-30. PMID 1330883 DOI: 10.1016/S0888-7543(05)80236-8  0.102
2018 Callaway DA, Campbell IM, Stover SR, Hernandez-Garcia A, Jhangiani SN, Punetha J, Paine IS, Posey JE, Muzny D, Lally KP, Lupski JR, Shaw CA, Fernandes CJ, Scott DA. Prioritization of Candidate Genes for Congenital Diaphragmatic Hernia in a Critical Region on Chromosome 4p16 using a Machine-Learning Algorithm. Journal of Pediatric Genetics. 7: 164-173. PMID 30430034 DOI: 10.1055/S-0038-1655755  0.102
2015 Campbell IM, Gambin T, Jhanghiani S, Grove ML, Veeraraghavan N, Muzny D, Shaw CA, Gibbs RA, Boerwinkle E, Yu F, Lupski JR. Multiallelic Positions in the Human Genome: Challenges for Genetic Analyses. Human Mutation. PMID 26670213 DOI: 10.1002/Humu.22944  0.102
2020 Kuang Y, Golan O, Preusse K, Cain B, Christensen CJ, Salomone J, Campbell I, Okwubido-Williams FV, Hass MR, Yuan Z, Eafergan N, Moberg KH, Kovall RA, Kopan R, Sprinzak D, et al. Enhancer architecture sensitizes cell-specific responses to gene dose via a bind and discard mechanism. Elife. 9. PMID 32297857 DOI: 10.7554/Elife.53659  0.101
2017 Davis SM, Thomas AL, Liu L, Campbell IM, Dierick HA. Isolation of Aggressive Behavior Mutants in Drosophila Using a Screen for Wing Damage. Genetics. PMID 29109180 DOI: 10.1534/genetics.117.300292  0.101
2020 Walters ME, Lacassie Y, Azamian M, Franciskovich R, Zapata G, Hernandez PP, Liu P, Campbell IM, Bostwick BL, Lalani SR. Vertical transmission of a large calvarial ossification defect due to heterozygous variants of ALX4 and TWIST1. American Journal of Medical Genetics. Part A. PMID 33369125 DOI: 10.1002/ajmg.a.62036  0.101
2008 Attwood SW, Fatih FA, Campbell I, Upatham ES. The distribution of Mekong schistosomiasis, past and future: preliminary indications from an analysis of genetic variation in the intermediate host. Parasitology International. 57: 256-70. PMID 18499512 DOI: 10.1016/j.parint.2008.04.003  0.101
2014 Campbell IM, Gambin T, Dittwald P, Beck CR, Shuvarikov A, Hixson P, Patel A, Gambin A, Shaw CA, Rosenfeld JA, Stankiewicz P. Human endogenous retroviral elements promote genome instability via non-allelic homologous recombination. Bmc Biology. 12: 74. PMID 25246103 DOI: 10.1186/S12915-014-0074-4  0.099
2013 Goode DL, Hunter SM, Doyle MA, Ma T, Rowley SM, Choong D, Ryland GL, Campbell IG. A simple consensus approach improves somatic mutation prediction accuracy. Genome Medicine. 5: 90. PMID 24073752 DOI: 10.1186/gm494  0.099
2014 Amarasinghe KC, Li J, Hunter SM, Ryland GL, Cowin PA, Campbell IG, Halgamuge SK. Inferring copy number and genotype in tumour exome data. Bmc Genomics. 15: 732. PMID 25167919 DOI: 10.1186/1471-2164-15-732  0.098
2013 Chong C, Walters D, de Silva P, Taylor C, Spillane A, Kollias J, Pyke C, Campbell I, Maddern G. Subsequent axillary surgery after sentinel lymph node biopsy: results from the BreastSurgANZ Quality Audit 2006-2010. Breast (Edinburgh, Scotland). 22: 1215-9. PMID 24157405 DOI: 10.1016/j.breast.2013.09.005  0.097
2018 Zeidan YH, Habib JG, Ameye L, Paesmans M, de Azambuja E, Gelber RD, Campbell I, Nordenskjöld B, Gutiérez J, Anderson M, Lluch A, Gnant M, Goldhirsch A, Di Leo A, Joseph DJ, et al. Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial. International Journal of Radiation Oncology, Biology, Physics. PMID 29534902 DOI: 10.1016/j.ijrobp.2018.01.105  0.097
2007 Jacobs S, Thompson ER, Nannya Y, Yamamoto G, Pillai R, Ogawa S, Bailey DK, Campbell IG. Genome-wide, high-resolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays. Cancer Research. 67: 2544-51. PMID 17363572 DOI: 10.1158/0008-5472.CAN-06-3597  0.095
2015 Elmadahm AA, Gill PG, Bochner M, Gebski VJ, Zannino D, Wetzig N, Campbell I, Stockler M, Ung O, Simes J, Uren R. Identification of the sentinel lymph node in the SNAC-1 trial. Anz Journal of Surgery. 85: 58-63. PMID 25626066 DOI: 10.1111/ans.12527  0.094
2022 Priestley JRC, Pace LM, Sen K, Aggarwal A, Alves CAPF, Campbell IM, Cuddapah SR, Engelhardt NM, Eskandar M, Jolín García PC, Gropman A, Helbig I, Hong X, Gowda VK, Lusk L, et al. Malate dehydrogenase 2 deficiency is an emerging cause of pediatric epileptic encephalopathy with a recognizable biochemical signature. Molecular Genetics and Metabolism Reports. 33: 100931. PMID 36420423 DOI: 10.1016/j.ymgmr.2022.100931  0.094
2023 Glewis S, Krishnasamy M, Lingaratnam S, Harris S, Underhill C, Georgiou C, Warren M, Campbell R, IJzerman M, Fagery M, Campbell I, Martin JH, Tie J, Alexander M, Michael M. Patient and health care professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: a cross sectional survey. Clinical and Translational Science. PMID 37877594 DOI: 10.1111/cts.13664  0.093
2012 Campbell IM, Yatsenko SA, Hixson P, Reimschisel T, Thomas M, Wilson W, Dayal U, Wheless JW, Crunk A, Curry C, Parkinson N, Fishman L, Riviello JJ, Nowaczyk MJ, Zeesman S, et al. Novel 9q34.11 gene deletions encompassing combinations of four Mendelian disease genes: STXBP1, SPTAN1, ENG, and TOR1A. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 14: 868-76. PMID 22722545 DOI: 10.1038/Gim.2012.65  0.092
2019 Gemine RE, Ghosal R, Collier G, Parry D, Campbell I, Davies G, Davies K, Lewis KE. Longitudinal study to assess impact of smoking at diagnosis and quitting on 1-year survival for people with non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 129: 1-7. PMID 30797485 DOI: 10.1016/j.lungcan.2018.12.028  0.092
2023 Gemine RE, Davies GR, Lanyon K, Rees SE, Campbell I, Lewis KE. Quitting smoking improves two-year survival after a diagnosis of non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 186: 107388. PMID 37820539 DOI: 10.1016/j.lungcan.2023.107388  0.091
2018 Kader T, Hill P, Rakha EA, Campbell IG, Gorringe KL. Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape. Breast Cancer Research : Bcr. 20: 39. PMID 29720211 DOI: 10.1186/s13058-018-0967-1  0.091
2016 Kader T, Goode DL, Wong SQ, Connaughton J, Rowley SM, Devereux L, Byrne D, Fox SB, Mir Arnau G, Tothill RW, Campbell IG, Gorringe KL. Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue. Genome Medicine. 8: 121. PMID 27846907 DOI: 10.1186/s13073-016-0375-z  0.091
2018 Campbell IM, Sheppard SE, Crowley TB, McGinn DE, Bailey A, McGinn MJ, Unolt M, Homans JF, Chen EY, Salmons HI, Gaynor JW, Goldmuntz E, Jackson OA, Katz LE, Mascarenhas MR, et al. What is new with 22q? An update from the 22q and You Center at the Children's Hospital of Philadelphia. American Journal of Medical Genetics. Part A. 176: 2058-2069. PMID 30380191 DOI: 10.1002/ajmg.a.40637  0.09
1995 Solic N, Collins JE, Richter A, Holt SJ, Campbell I, Alexander P, Davies DE. Two newly established cell lines derived from the same colonic adenocarcinoma exhibit differences in EGF-receptor ligand and adhesion molecule expression International Journal of Cancer. 62: 48-57. PMID 7601566 DOI: 10.1002/Ijc.2910620111  0.09
2010 Wong G, Leckie C, Gorringe KL, Haviv I, Campbell IG, Kowalczyk A. Exploiting sequence similarity to validate the sensitivity of SNP arrays in detecting fine-scaled copy number variations. Bioinformatics (Oxford, England). 26: 1007-14. PMID 20189937 DOI: 10.1093/bioinformatics/btq088  0.089
2011 Pope WH, Jacobs-Sera D, Russell DA, Peebles CL, Al-Atrache Z, Alcoser TA, Alexander LM, Alfano MB, Alford ST, Amy NE, Anderson MD, Anderson AG, Ang AA, Ares M, Barber AJ, ... ... Campbell IW, et al. Expanding the diversity of mycobacteriophages: insights into genome architecture and evolution. Plos One. 6: e16329. PMID 21298013 DOI: 10.1371/Journal.Pone.0016329  0.089
2021 Gold NB, Campbell IM, Sheppard SE, Tan WH. Proposed criteria for nevoid basal cell carcinoma syndrome in children assessed using statistical optimization. Scientific Reports. 11: 19791. PMID 34611197 DOI: 10.1038/s41598-021-98752-9  0.087
2023 Weissenbacher D, Rawal S, Zhao X, Priestley JRC, Szigety KM, Schmidt SF, Higgins MJ, Magge A, O'Connor K, Gonzalez-Hernandez G, Campbell IM. PheNorm, a language model normalizer of physical examinations from genetics clinical notes. Medrxiv : the Preprint Server For Health Sciences. PMID 37904943 DOI: 10.1101/2023.10.16.23296894  0.087
2015 Startek M, Szafranski P, Gambin T, Campbell IM, Hixson P, Shaw CA, Stankiewicz P, Gambin A. Genome-wide analyses of LINE-LINE-mediated nonallelic homologous recombination. Nucleic Acids Research. 43: 2188-98. PMID 25613453 DOI: 10.1093/Nar/Gku1394  0.086
2016 Lung M, Trainer A, Campbell I. Identification of novel CRC pathway genes in familial CRC Annals of Oncology. 27: vi2. DOI: 10.1093/annonc/mdw362.07  0.085
2018 Campbell I, Lundstrom S, Larsson H, Lichtenstein P, Lubke G. The relation between the age at diagnosis of problem behaviors related to aggression and distal outcomes in Swedish children. European Child & Adolescent Psychiatry. PMID 30413982 DOI: 10.1007/S00787-018-1250-9  0.085
2022 Campbell IM, Crowley TB, Jobaliya C, Bailey A, McGinn DE, Gaiser K, Bassett A, Gur RE, Morrow B, Emanuel BS, Franco AT, French D, Zackai EH, McDonald-McGinn DM, Lambert MP. Platelet findings in 22q11.2 deletion syndrome correlate with disease manifestations but do not correlate with GPIb surface expression. Clinical Genetics. PMID 36075864 DOI: 10.1111/cge.14227  0.083
2007 Damato B, Duke C, Coupland SE, Hiscott P, Smith PA, Campbell I, Douglas A, Howard P. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology. 114: 1925-31. PMID 17719643 DOI: 10.1016/j.ophtha.2007.06.012  0.082
2021 Parenteau CS, Lau EC, Campbell IC, Courtney A. Prevalence of spine degeneration diagnosis by type, age, gender, and obesity using Medicare data. Scientific Reports. 11: 5389. PMID 33686128 DOI: 10.1038/s41598-021-84724-6  0.081
2015 Mayle R, Campbell IM, Beck CR, Yu Y, Wilson M, Shaw CA, Bjergbaek L, Lupski JR, Ira G. DNA REPAIR. Mus81 and converging forks limit the mutagenicity of replication fork breakage. Science (New York, N.Y.). 349: 742-7. PMID 26273056 DOI: 10.1126/Science.Aaa8391  0.081
2023 Crowley TB, Campbell I, Arulselvan A, Friedman D, Zackai EH, Geoffrion TR, Witmer C, Gaynor JW, McDonald-McGinn DM, Lambert MP. A case-control study of bleeding risk in children with 22q11.2 deletion syndrome undergoing cardiac surgery. Platelets. 35: 2290108. PMID 38099325 DOI: 10.1080/09537104.2023.2290108  0.079
2012 Li J, Lupat R, Amarasinghe KC, Thompson ER, Doyle MA, Ryland GL, Tothill RW, Halgamuge SK, Campbell IG, Gorringe KL. CONTRA: copy number analysis for targeted resequencing. Bioinformatics (Oxford, England). 28: 1307-13. PMID 22474122 DOI: 10.1093/bioinformatics/bts146  0.077
2022 Campbell NV, Mickael C, Kumar S, Zhang H, Campbell IL, Gillen AE, Trentin CO, Diener K, Gao B, Kheyfets VO, Gu S, Kumar R, Phang T, Brown RD, Graham BB, et al. Single Cell RNA Sequencing and Binary Hierarchical Clustering Defines Lung Interstitial Macrophage Heterogeneity in Response to Hypoxia. American Journal of Physiology. Lung Cellular and Molecular Physiology. PMID 35608266 DOI: 10.1152/ajplung.00104.2022  0.077
2019 Campbell IJ, Bennett GN, Silberg JJ. Evolutionary Relationships Between Low Potential Ferredoxin and Flavodoxin Electron Carriers. Frontiers in Energy Research. 7. PMID 32095484 DOI: 10.3389/fenrg.2019.00079  0.077
2021 Gold JI, Campbell IM, Ficicioglu C. Provider Perspectives on the Impact of the COVID-19 Pandemic on Newborn Screening. International Journal of Neonatal Screening. 7. PMID 34287223 DOI: 10.3390/ijns7030038  0.075
2018 Zandvakili A, Uhl JD, Campbell I, Salomone J, Song YC, Gebelein B. The cis-regulatory logic underlying abdominal Hox-mediated repression versus activation of regulatory elements in Drosophila. Developmental Biology. PMID 30468713 DOI: 10.1016/J.Ydbio.2018.11.006  0.074
2008 Coupland SE, Campbell I, Damato B. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Ophthalmology. 115: 1778-85. PMID 18554722 DOI: 10.1016/j.ophtha.2008.04.025  0.073
2007 Reddick LE, Vaughn MD, Wright SJ, Campbell IM, Bruce BD. In vitro comparative kinetic analysis of the chloroplast Toc GTPases. The Journal of Biological Chemistry. 282: 11410-26. PMID 17261588 DOI: 10.1074/Jbc.M609491200  0.072
2017 Campbell IC, Hannon BG, Read AT, Sherwood JM, Schwaner SA, Ethier CR. Quantification of the efficacy of collagen cross-linking agents to induce stiffening of rat sclera. Journal of the Royal Society, Interface. 14. PMID 28381643 DOI: 10.1098/rsif.2017.0014  0.071
2011 Hurley JJ, Turner J, Campbell IA, Dolwani S. An opportune finding in suspected liver metastases. Bmj Case Reports. 2011. PMID 22707572 DOI: 10.1136/bcr.05.2010.3013  0.071
2019 Feola AJ, Fu J, Allen R, Yang V, Campbell IC, Ottensmeyer A, Ethier CR, Pardue M. Menopause exacerbates visual dysfunction in experimental glaucoma. Experimental Eye Research. 107706. PMID 31226338 DOI: 10.1016/J.Exer.2019.107706  0.07
2011 Campbell IG, Bromberger JT, Buysse DJ, Hall MH, Hardin KA, Kravitz HM, Matthews KA, Rasor MO, Utts J, Gold E. Evaluation of the association of menopausal status with delta and beta EEG activity during sleep. Sleep. 34: 1561-8. PMID 22043127 DOI: 10.5665/Sleep.1398  0.07
2023 Campbell IM, Karavite DJ, Mcmanus ML, Cusick FC, Junod DC, Sheppard SE, Lourie EM, Shelov ED, Hakonarson H, Luberti AA, Muthu N, Grundmeier RW. Clinical decision support with a comprehensive in-EHR patient tracking system improves genetic testing follow up. Journal of the American Medical Informatics Association : Jamia. PMID 37080563 DOI: 10.1093/jamia/ocad070  0.069
2018 Spirig R, Campbell IK, Koernig S, Chen CG, Lewis BJB, Butcher R, Muir I, Taylor S, Chia J, Leong D, Simmonds J, Scotney P, Schmidt P, Fabri L, Hofmann A, et al. rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs. Journal of Immunology (Baltimore, Md. : 1950). PMID 29531170 DOI: 10.4049/jimmunol.1701171  0.069
2021 Boyero L, López-Rojo N, Tonin AM, Pérez J, Correa-Araneda F, Pearson RG, Bosch J, Albariño RJ, Anbalagan S, Barmuta LA, Basaguren A, Burdon FJ, Caliman A, Callisto M, Calor AR, ... Campbell IC, et al. Impacts of detritivore diversity loss on instream decomposition are greatest in the tropics. Nature Communications. 12: 3700. PMID 34140471 DOI: 10.1038/s41467-021-23930-2  0.069
2018 Zandvakili A, Campbell I, Gutzwiller LM, Weirauch MT, Gebelein B. Degenerate Pax2 and Senseless binding motifs improve detection of low-affinity sites required for enhancer specificity. Plos Genetics. 14: e1007289. PMID 29617378 DOI: 10.1371/Journal.Pgen.1007289  0.068
2004 Campbell IK, Roberts LJ, Wicks IP. Molecular targets in immune-mediated diseases: the case of tumour necrosis factor and rheumatoid arthritis. Immunology and Cell Biology. 81: 354-66. PMID 12969323 DOI: 10.1046/j.0818-9641.2003.01185.x  0.068
2022 Qu HQ, Glessner J, Qu J, Mentch F, Campbell I, Sleiman P, Connolly JJ, Hakonarson H. Metabolomic profiling for dyslipidemia in pediatric patients with sickle cell disease, on behalf of the IHCC consortium. Metabolomics : Official Journal of the Metabolomic Society. 18: 101. PMID 36459297 DOI: 10.1007/s11306-022-01954-z  0.067
2019 Mutter AC, Tyryshkin AM, Campbell IJ, Poudel S, Bennett GN, Silberg JJ, Nanda V, Falkowski PG. De novo design of symmetric ferredoxins that shuttle electrons in vivo. Proceedings of the National Academy of Sciences of the United States of America. PMID 31262814 DOI: 10.1073/Pnas.1905643116  0.066
2013 Lawlor KE, van Nieuwenhuijze A, Parker KL, Drake SF, Campbell IK, Smith SD, Vince JE, Strasser A, Wicks IP. Bcl-2 overexpression ameliorates immune complex-mediated arthritis by altering FcγRIIb expression and monocyte homeostasis. Journal of Leukocyte Biology. 93: 585-97. PMID 23341540 DOI: 10.1189/jlb.0412190  0.066
2008 Caminschi I, Proietto AI, Ahmet F, Kitsoulis S, Shin Teh J, Lo JC, Rizzitelli A, Wu L, Vremec D, van Dommelen SL, Campbell IK, Maraskovsky E, Braley H, Davey GM, Mottram P, et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood. 112: 3264-73. PMID 18669894 DOI: 10.1182/blood-2008-05-155176  0.066
2022 Feio MJ, Hughes RM, Serra SRQ, Nichols SJ, Kefford BJ, Lintermans M, Robinson W, Odume ON, Callisto M, Macedo DR, Harding JS, Yates AG, Monk W, Nakamura K, Mori T, ... ... Campbell I, et al. Fish and macroinvertebrate assemblages reveal extensive degradation of the world's rivers. Global Change Biology. PMID 36131677 DOI: 10.1111/gcb.16439  0.064
2006 Wood L, Wall D, Bullock A, Hassell A, Whitehouse A, Campbell I. 'Team observation': a six-year study of the development and use of multi-source feedback (360-degree assessment) in obstetrics and gynaecology training in the UK. Medical Teacher. 28: e177-84. PMID 17594543 DOI: 10.1080/01421590600834260  0.063
2021 Crowley TB, Campbell IM, Liebling EJ, Lambert MP, Levitt Katz LE, Heimall J, Bailey A, McGinn DE, McDonald McGinn DM, Sullivan KE. Distinct immune trajectories in patients with chromosome 22q11.2 deletion syndrome and immune-mediated diseases. The Journal of Allergy and Clinical Immunology. PMID 34144109 DOI: 10.1016/j.jaci.2021.06.007  0.063
2023 Múnera JO, Kechele DO, Bouffi C, Qu N, Jing R, Maity P, Enriquez JR, Han L, Campbell I, Mahe MM, McCauley HA, Zhang X, Sundaram N, Hudson JR, Zarsozo-Lacoste A, et al. Development of functional resident macrophages in human pluripotent stem cell-derived colonic organoids and human fetal colon. Cell Stem Cell. 30: 1434-1451.e9. PMID 37922878 DOI: 10.1016/j.stem.2023.10.002  0.063
2005 Stanton H, Rogerson FM, East CJ, Golub SB, Lawlor KE, Meeker CT, Little CB, Last K, Farmer PJ, Campbell IK, Fourie AM, Fosang AJ. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature. 434: 648-52. PMID 15800625 DOI: 10.1038/nature03417  0.063
2009 Giugliano D, Standl E, Vilsbøll T, Betteridge J, Bonadonna R, Campbell IW, Schernthaner GH, Staels B, Trichopoulou A, Farinaro E. Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings? Acta Diabetologica. 46: 173-81. PMID 19543848 DOI: 10.1007/s00592-009-0134-3  0.062
2018 Courtney A, Campbell IC, Courtney E, Pasquesi SA. Risk of concussion due to head acceleration in rear impact sled tests of passenger automobile seats. Traffic Injury Prevention. 19: S133-S135. PMID 30841805 DOI: 10.1080/15389588.2018.1532200  0.062
2005 Campbell IG, Feinberg I. Homeostatic sleep response to naps is similar in normal elderly and young adults. Neurobiology of Aging. 26: 135-44. PMID 15585353 DOI: 10.1016/j.neurobiolaging.2004.02.021  0.061
2020 Campbell IJ, Olmos JL, Xu W, Kahanda D, Atkinson JT, Sparks ON, Miller MD, Phillips GN, Bennett GN, Silberg JJ. phage ferredoxin: Structural characterization and electron transfer to cyanobacterial sulfite reductases. The Journal of Biological Chemistry. PMID 32434930 DOI: 10.1074/Jbc.Ra120.013501  0.061
2004 Palagini L, Gemignani A, Feinberg I, Guazzelli M, Campbell IG. Mental activity after early afternoon nap awakenings in healthy subjects. Brain Research Bulletin. 63: 361-8. PMID 15245762 DOI: 10.1016/J.Brainresbull.2003.12.008  0.061
2011 Campbell IH, Austin D, Hayes TL, Pavel M, Riley T, Mattek N, Kaye J. Measuring changes in activity patterns during a norovirus epidemic at a retirement community. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2011: 6793-6. PMID 22255898 DOI: 10.1109/IEMBS.2011.6091675  0.061
2014 Talkish J, Campbell IW, Sahasranaman A, Jakovljevic J, Woolford JL. Ribosome assembly factors Pwp1 and Nop12 are important for folding of 5.8S rRNA during ribosome biogenesis in Saccharomyces cerevisiae. Molecular and Cellular Biology. 34: 1863-77. PMID 24636992 DOI: 10.1128/Mcb.01322-13  0.061
1996 Ingamells S, Campbell IG, Anthony FW, Thomas EJ. Endometrial progesterone receptor expression during the human menstrual cycle. Journal of Reproduction and Fertility. 106: 33-8. PMID 8667343 DOI: 10.1530/JRF.0.1060033  0.061
2006 Konstantakopoulos N, Larsen MR, Campbell IG, Quinn MA, Baker MS, Georgiou HM, Rice GE. Genistein-induced proteome changes in the human endometrial carcinoma cell line, Ishikawa Clinical Proteomics. 2: 153-167. DOI: 10.1007/BF02752498  0.06
2022 Campbell IJ, Atkinson JT, Carpenter MD, Myerscough D, Su L, Ajo-Franklin CM, Silberg JJ. Determinants of Multiheme Cytochrome Extracellular Electron Transfer Uncovered by Systematic Peptide Insertion. Biochemistry. PMID 35687533 DOI: 10.1021/acs.biochem.2c00148  0.06
2013 Feinberg I, Campbell IG. Longitudinal sleep EEG trajectories indicate complex patterns of adolescent brain maturation. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 304: R296-303. PMID 23193115 DOI: 10.1152/ajpregu.00422.2012  0.06
2016 Campbell IM, Shaw CA, Stankiewicz P, Lupski JR. Erratum to: Somatic Mosaicism: Implications for Disease and Transmission Genetics. Trends in Genetics : Tig. 32: 138. PMID 29482722 DOI: 10.1016/J.Tig.2015.07.004  0.06
2021 Zhang ZY, Campbell IG, Dhayagude P, Espino HC, Feinberg I. Longitudinal analysis of sleep spindle maturation from childhood through late adolescence. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33785642 DOI: 10.1523/JNEUROSCI.2370-20.2021  0.059
2009 Campbell IG, Feinberg I. Longitudinal trajectories of non-rapid eye movement delta and theta EEG as indicators of adolescent brain maturation. Proceedings of the National Academy of Sciences of the United States of America. 106: 5177-80. PMID 19307577 DOI: 10.1073/pnas.0812947106  0.059
2020 Tiller J, Trainer AH, Campbell I, Lacaze PA. Ethical and practical implications of returning genetic research results: two Australian case studies. The Medical Journal of Australia. PMID 33161572 DOI: 10.5694/mja2.50842  0.059
2012 Campbell IH, O'Neill HS. Evidence against a chondritic Earth. Nature. 483: 553-8. PMID 22460899 DOI: 10.1038/Nature10901  0.059
2014 Campbell IC, Suever JD, Timmins LH, Veneziani A, Vito RP, Virmani R, Oshinski JN, Taylor WR. Biomechanics and inflammation in atherosclerotic plaque erosion and plaque rupture: implications for cardiovascular events in women. Plos One. 9: e111785. PMID 25365517 DOI: 10.1371/Journal.Pone.0111785  0.058
2019 Feinberg I, Campbell IG. Shorter sleep durations in adolescents reduce power density in a wide range of waking electroencephalogram frequencies. Plos One. 14: e0210649. PMID 30668606 DOI: 10.1371/journal.pone.0210649  0.058
2010 Verma H, Nicholson AG, Kerr KM, Dempsey OJ, Gibbs AR, Campbell I, Black F, Rassl D, Rice AJ, Renzoni EA, Wells AU, Hansell DM. Alveolar proteinosis with hypersensitivity pneumonitis: a new clinical phenotype. Respirology (Carlton, Vic.). 15: 1197-202. PMID 20920129 DOI: 10.1111/j.1440-1843.2010.01848.x  0.057
2018 Murphy SE, Campbell I, Drew JA. Examination of tourists' willingness to pay under different conservation scenarios; Evidence from reef manta ray snorkeling in Fiji. Plos One. 13: e0198279. PMID 30067743 DOI: 10.1371/Journal.Pone.0198279  0.057
2014 Campbell IK, Miescher S, Branch DR, Mott PJ, Lazarus AH, Han D, Maraskovsky E, Zuercher AW, Neschadim A, Leontyev D, McKenzie BS, Käsermann F. Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils. Journal of Immunology (Baltimore, Md. : 1950). 192: 5031-8. PMID 24760152 DOI: 10.4049/Jimmunol.1301611  0.057
2023 Truong A, Myerscough D, Campbell I, Atkinson J, Silberg JJ. A cellular selection identifies elongated flavodoxins that support electron transfer to sulfite reductase. Protein Science : a Publication of the Protein Society. e4746. PMID 37551563 DOI: 10.1002/pro.4746  0.057
2022 Szigety KM, Crowley TB, Gaiser KB, Chen EY, Priestley JRC, Williams LS, Rangu SA, Wright CM, Adusumalli P, Ahrens-Nicklas RC, Calderon B, Cuddapah SR, Edmondson A, Ficicioglu C, Ganetzky R, ... ... Campbell IM, et al. Clinical Effectiveness of Telemedicine-Based Pediatric Genetics Care. Pediatrics. PMID 35642503 DOI: 10.1542/peds.2021-054520  0.057
2005 Tan Sardjono C, Mottram PL, van de Velde NC, Powell MS, Power D, Slocombe RF, Wicks IP, Campbell IK, McKenzie SE, Brooks M, Stevenson AW, Hogarth PM. Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic mice. Arthritis and Rheumatism. 52: 3220-9. PMID 16200626 DOI: 10.1002/Art.21344  0.057
2002 Cook AD, Braine EL, Campbell IK, Hamilton JA. Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis. The American Journal of Pathology. 160: 917-26. PMID 11891190 DOI: 10.1016/S0002-9440(10)64914-0  0.056
2023 Campbell IW, Hullahalli K, Turner JR, Waldor MK. Quantitative dose-response analysis untangles host bottlenecks to enteric infection. Nature Communications. 14: 456. PMID 36709326 DOI: 10.1038/s41467-023-36162-3  0.056
2012 Campbell IG, Grimm KJ, de Bie E, Feinberg I. Sex, puberty, and the timing of sleep EEG measured adolescent brain maturation. Proceedings of the National Academy of Sciences of the United States of America. 109: 5740-3. PMID 22451933 DOI: 10.1073/Pnas.1120860109  0.055
2010 Feinberg I, Campbell IG. Sleep EEG changes during adolescence: an index of a fundamental brain reorganization. Brain and Cognition. 72: 56-65. PMID 19883968 DOI: 10.1016/j.bandc.2009.09.008  0.055
2019 Koernig S, Campbell IK, Mackenzie-Kludas C, Schaub A, Loetscher M, Ching Ng W, Zehnder R, Pelczar P, Sanli I, Alhamdoosh M, Ng M, Brown LE, Käsermann F, Vonarburg C, Zuercher AW. Topical application of human-derived Ig isotypes for the control of acute respiratory infection evaluated in a human CD89-expressing mouse model. Mucosal Immunology. PMID 31105268 DOI: 10.1038/s41385-019-0167-z  0.055
2002 Bodman-Smith KB, Melendez AJ, Campbell I, Harrison PT, Allen JM, Raynes JG. C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI). Immunology. 107: 252-60. PMID 12383205 DOI: 10.1046/j.1365-2567.2002.01481.x  0.055
2019 Crow AR, Kapur R, Koernig S, Campbell IK, Jen CC, Mott PJ, Marjoram D, Khan R, Kim M, Brasseit J, Cruz-Leal Y, Amash A, Kahlon S, Yougbare I, Ni H, et al. Treating murine inflammatory diseases with an anti-erythrocyte antibody. Science Translational Medicine. 11. PMID 31434758 DOI: 10.1126/scitranslmed.aau8217  0.055
2012 Chotewutmontri P, Reddick LE, McWilliams DR, Campbell IM, Bruce BD. Differential transit peptide recognition during preprotein binding and translocation into flowering plant plastids. The Plant Cell. 24: 3040-59. PMID 22829148 DOI: 10.1105/Tpc.112.098327  0.054
2004 Darchia N, Campbell IG, Palagini L, Feinberg I. Rapid eye movement density shows trends across REM periods but is uncorrelated with NREM delta in young and elderly human subjects. Brain Research Bulletin. 63: 433-8. PMID 15245772 DOI: 10.1016/j.brainresbull.2003.12.017  0.054
2022 Abouhajar A, Alcock L, Bigirumurame T, Bradley P, Brown L, Campbell I, Del Din S, Faitg J, Falkous G, Gorman GS, Lakey R, McFarland R, Newman J, Rochester L, et al. Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy. Trials. 23: 789. PMID 36127727 DOI: 10.1186/s13063-022-06544-x  0.054
2017 Mills CM, Danovitch JH, Rowles SP, Campbell IL. Children's success at detecting circular explanations and their interest in future learning. Psychonomic Bulletin & Review. PMID 28176292 DOI: 10.3758/S13423-016-1195-2  0.054
2018 Atkinson JT, Campbell IJ, Thomas EE, Bonitatibus SC, Elliott SJ, Bennett GN, Silberg JJ. Metalloprotein switches that display chemical-dependent electron transfer in cells. Nature Chemical Biology. PMID 30559426 DOI: 10.1038/S41589-018-0192-3  0.054
2020 Roman L, Hardesty BD, Leonard GH, Pragnell-Raasch H, Mallos N, Campbell I, Wilcox C. A global assessment of the relationship between anthropogenic debris on land and the seafloor. Environmental Pollution (Barking, Essex : 1987). 264: 114663. PMID 32388297 DOI: 10.1016/J.Envpol.2020.114663  0.054
2013 Hoskins W, Taylor P, Jacob A, Wijeratne S, Campbell I. Colectomies performed at a rural Australian hospital: a 7-year analysis. The Australian Journal of Rural Health. 21: 279-84. PMID 24118151 DOI: 10.1111/ajr.12058  0.054
2018 Michael M, Pook DW, Ganju V, Link E, Toner GC, Hicks RJ, Matera A, Thompson M, Cullinane C, Campbell I, Burge M, Karapetis CS. The utility of genomics and functional imaging to predict Sunitinib PK and PD: The Predict SU study. Journal of Clinical Oncology. 36: 2563-2563. DOI: 10.1200/Jco.2018.36.15_Suppl.2563  0.053
2021 Robson S, McParlin C, Mossop H, Lie M, Fernandez-Garcia C, Howel D, Graham R, Ternent L, Steel A, Goudie N, Nadeem A, Phillipson J, Shehmar M, Simpson N, Tuffnell D, ... Campbell I, et al. Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCT. Health Technology Assessment (Winchester, England). 25: 1-116. PMID 34782054 DOI: 10.3310/hta25630  0.053
2018 Campbell IG, Van Dongen HPA, Gainer M, Karmouta E, Feinberg I. Differential and interacting effects of age and sleep restriction on daytime sleepiness and vigilance in adolescence: a longitudinal study. Sleep. PMID 30169721 DOI: 10.1093/sleep/zsy177  0.053
2016 Campbell IS, Howell JD, Evans HH. Visceral Vistas: Basil Hirschowitz and the Birth of Fiberoptic Endoscopy. Annals of Internal Medicine. 165: 214-218. PMID 27479222 DOI: 10.7326/M16-0025  0.053
2021 Darchia N, Campbell IG, Basishvili T, Eliozishvili M, Tchintcharauli T, Oniani N, Sakhelashvili I, Shetekauri T, Oniani T, Feinberg I. Longitudinal assessment of NREM sleep EEG in typically developing and medication-free ADHD adolescents: first year results. Sleep Medicine. 80: 171-175. PMID 33601229 DOI: 10.1016/j.sleep.2021.01.052  0.053
2020 Campbell IJ, Kahanda D, Atkinson JT, Sparks ON, Kim J, Tseng CP, Verduzco R, Bennett GN, Silberg JJ. Recombination of 2Fe-2S Ferredoxins Reveals Differences in the Inheritance of Thermostability and Midpoint Potential. Acs Synthetic Biology. PMID 33226772 DOI: 10.1021/acssynbio.0c00303  0.053
2002 Campbell IG, Gustafson LM, Feinberg I. The competitive NMDA receptor antagonist CPPene stimulates NREM sleep and eating in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 348-57. PMID 11850149 DOI: 10.1016/S0893-133X(01)00363-3  0.053
2017 Campbell IG, Burright CS, Kraus AM, Grimm KJ, Feinberg I. Daytime sleepiness increases with age in early adolescence: a sleep restriction dose-response study. Sleep. PMID 28419388 DOI: 10.1093/Sleep/Zsx046  0.053
2002 Kam E, Eslick G, Campbell I. An audit of the effectiveness of acupuncture on musculoskeletal pain in primary health care. Acupuncture in Medicine : Journal of the British Medical Acupuncture Society. 20: 35-8. PMID 11926604 DOI: 10.1136/aim.20.1.35  0.052
2014 Rowe CJ, Campbell IS, Hargrave LA. Rural experience for junior doctors: Is it time to make it mandatory? Australian Journal of Rural Health. 22: 63-67. PMID 24731202 DOI: 10.1111/ajr.12082  0.052
2016 Goldberg GL, Cornish AL, Murphy J, Pang ES, Lim LL, Campbell IK, Scalzo-Inguanti K, Chen X, McMenamin PG, Maraskovsky E, McKenzie BS, Wicks IP. G-CSF and Neutrophils Are Nonredundant Mediators of Murine Experimental Autoimmune Uveoretinitis. The American Journal of Pathology. 186: 172-84. PMID 26718978 DOI: 10.1016/j.ajpath.2015.09.008  0.052
2009 Arculus R, Campbell IH, McLennan SM, Taylor SR. Asteroids and andesites. Nature. 459: E1; discussion E2. PMID 19478728 DOI: 10.1038/Nature08077  0.052
2009 Cornish AL, Campbell IK, McKenzie BS, Chatfield S, Wicks IP. G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis Nature Reviews Rheumatology. 5: 554-559. PMID 19798030 DOI: 10.1038/nrrheum.2009.178  0.051
2023 Hardin J, Seltzer J, Galust H, Deguzman A, Campbell I, Friedman N, Wardi G, Clark RF, Lasoff D. Emergency Department Take-Home Naloxone Improves Access Compared with Pharmacy-Dispensed Naloxone. The Journal of Emergency Medicine. PMID 38461132 DOI: 10.1016/j.jemermed.2023.11.020  0.051
2012 Campbell IC, Ries J, Dhawan SS, Quyyumi AA, Taylor WR, Oshinski JN. Effect of inlet velocity profiles on patient-specific computational fluid dynamics simulations of the carotid bifurcation. Journal of Biomechanical Engineering. 134: 051001. PMID 22757489 DOI: 10.1115/1.4006681  0.051
2022 Campbell IG, Kim EI, Darchia N, Feinberg I. Sleep restriction and age effects on waking alpha EEG activity in adolescents. Sleep Advances : a Journal of the Sleep Research Society. 3: zpac015. PMID 35669317 DOI: 10.1093/sleepadvances/zpac015  0.051
2004 Beswick P, Bingham S, Bountra C, Brown T, Browning K, Campbell I, Chessell I, Clayton N, Collins S, Corfield J, Guntrip S, Haslam C, Lambeth P, Lucas F, Mathews N, et al. Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14: 5445-8. PMID 15454242 DOI: 10.1016/j.bmcl.2004.07.089  0.051
2011 Campbell IS, Ton AT, Mulligan CC. Direct detection of pharmaceuticals and personal care products from aqueous samples with thermally-assisted desorption electrospray ionization mass spectrometry. Journal of the American Society For Mass Spectrometry. 22: 1285-93. PMID 21953111 DOI: 10.1007/S13361-011-0144-6  0.051
2021 Boyero L, Pérez J, López-Rojo N, Tonin AM, Correa-Araneda F, Pearson RG, Bosch J, Albariño RJ, Anbalagan S, Barmuta LA, Beesley L, Burdon FJ, Caliman A, Callisto M, Campbell IC, et al. Latitude dictates plant diversity effects on instream decomposition. Science Advances. 7. PMID 33771867 DOI: 10.1126/sciadv.abe7860  0.051
2019 Vonarburg C, Loetscher M, Spycher MO, Kropf A, Illi M, Salmon S, Roberts S, Steinfuehrer K, Campbell I, Koernig S, Bain J, Edler M, Baumann U, Miescher S, Metzger DW, et al. Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates. Respiratory Research. 20: 99. PMID 31118031 DOI: 10.1186/s12931-019-1057-3  0.05
2023 Lang C, Fruth A, Campbell IW, Jenkins C, Smith P, Strockbine N, Weill FX, Nübel U, Grad YH, Waldor MK, Flieger A. O-Antigen Diversification Masks Identification of Highly Pathogenic Shiga Toxin-Producing Escherichia coli O104:H4-Like Strains. Microbiology Spectrum. e0098723. PMID 37212677 DOI: 10.1128/spectrum.00987-23  0.05
Hide low-probability matches.